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Engineering of bulk tissues has been limited by the lack of nutrient and 
waste exchange in these tissues without an adjacent capillary network. To produce 
microvasculature, a scaffold must be produced that provides temporary 
mechanical support and stimulate endothelial cell adhesion, growth, and 
morphogenesis into a vessel. However, current well-established techniques for 
producing microvasculature, such as electrospinning, are limited since they lack 
both the precision to control fiber placement in three-dimensional space and the 
ability to create fiber networks with predefined diameters to replicate the 
physiological microvascular progression from arteriole to capillary to venule. Our 
group has developed a “Direct-write” technique using a 3-Axis robotic dispensing 
system to process polymers into precisely positioned, three-dimensional, 
suspended fibers with controlled diameters. 
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Within this dissertation, a conceptual scaffold-covering strategy is 
presented for the formation of the precisely positioned, three-dimensional 
microvascular structure with a controlled diameter in vitro. This study considers 
ways to extend the 3-Axis robotic dispensing system by incorporating new 
biodegradable materials into micro-fibers. First, a number of different biopolymers 
(natural, synthetic, composites, and copolymers) were used for demonstrating the 
capability of direct-writing micro-fibers and branched structures with 
microvascular-scale diameter through the 3-Axial robotic dispensing system. Then, 
the fabrication process was characterized by a design of experiments and a 
generalized mathematical model was developed through dimensional analysis. 
The empirical model determined the correlation between polymer fiber diameter 
and intrinsic properties of the polymer solution together with the processing 
parameters of the robotic dispensing system and allows future users the ability to 
employ the 3-Axis robotic dispensing system to direct-write micro-fibers without 
trial-and-error work. This study also considers ways to broaden the pre-
vascularization methods by covering Human Dermal Microvascular Endothelial 
Cells (HDMECs) on the fabricated scaffold to generate the microvascular structure. 
HDMECs cultured on the produced micro-fiber scaffolds were observed to form a 
confluent monolayer spread along the axis and around the circumference of the 
fibers within two days of seeding. Once confluency was reached, the cell-covered 
scaffold was embedded into a collagen gel and a hybrid structure was formed. 
Through these experiments, we demonstrate the ability to obtain a cell-viable, 
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flexible, and free-standing “modular tissue”, which could be potentially assembled 
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CHAPTER 1:  INTRODUCTION 
 
Tissue and organ failure caused by disease or injury has become a major 
health dilemma in the world, accounting for ~40% of the annual total causes of 
death in 2015 [1]. There are four principal therapeutic strategies for treating tissue 
and organ failure in patients: surgical repair, artificial prostheses, mechanical 
devices, and transplantation (human or xenotransplantation) [2]. Although these 
therapies have saved innumerable patients' lives, they are still far from perfect 
solutions. A surgical repair usually leads to long-term complications for the patient. 
For example, hepatic resection often develops serious postoperative morbidity, the 
most common being bile leak and associated perihepatic abscess [3]. Artificial 
prostheses and mechanical devices neither perform the full physiological function 
nor adequately repair/restore full organ function. Moreover, artificial prostheses 
and mechanical devices are generally subjected to wear upon long-term 
implantation, which can induce an inflammatory response in the patient [4]. For 
some patients with end-stage organ failure, such as heart and liver failure, 
transplantation is the most effective way to save their lives. However, organ 
transplantation suffers from severe donor shortage. Specifically, according to 
Organ Procurement and Transplantation Network Data Reports, there are 
116,000+ patients on the national transplant waiting list as of August 2017. Only 
33,611 transplants were performed in 2016, and the vast imbalance between the 
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number of organ donors and patients waiting for donor transplants worsens every 
year [5]. 
Tissue engineering is an approach with significant potential for solving the 
organ donor shortage problem. The concept of tissue engineering was first 
introduced by Robert Langer and Joseph Vacanti in the first NSF-sponsored 
meeting on tissue engineering in 1988, which described the concept as “attaching 
cell preparations to bioerodable artificial polymers in cell culture and then 
implanting this polymer-cell scaffold into animals” [6]. In 1993, the pioneering paper 
entitled “Tissue Engineering” appeared in Science, which further defined tissue 
engineering as “an interdisciplinary field that applies the principles of engineering 
and the life sciences toward the development of biological substitutes that restore, 
maintain, or improve tissue function” [7]. The main goal of tissue engineering is to 
create functional tissues and organs in vitro and then transplant them into the host. 
After decades of rapid development, scientists and engineers have begun to 
design and engineer vital organs/structures in the laboratory, including the liver, 
spinal cord, blood vessels, cartilages, hearts valves, skin, bones, intestines, 
urological structures, tendons, and muscles [8-12]. Overall, most engineered 
tissues have not realized commercial success, primarily due to the need for a 
sustainable, highly branched system of blood vessels and microvascular network 
to enable the exchange of nutrients and waste products. Only a few engineered 
tissues, such as skin and cartilage [13-18] have been successful clinically since 
they can be manufactured without vascular or neural networks. However, progress 
on producing larger and more complex tissues and organs has hampered by the 
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lack of ability to create engineering microvascular network that meet the metabolic 
needs of the tissues after implantation [19-21]. 
Thus, the capability to selectively produce a microvascular network has 
become an emerging field of tissue engineering. Both in vivo and in vitro methods 
have been proposed for the development of the engineered microvasculature. 
Vasculogenesis and angiogenesis are the two fundamental processes involved in 
new blood vessel formation in vivo [22, 23]. There are three different models that 
have been studied in vivo to form microvascular lumen: (1) vacuole formation and 
coalescence, (2) wrapping around extracellular space, and (3) cell death and 
phagocytosis [24]. This research may answer many important questions about 
microvasculature development, such as how endothelial cells could form a luminal 
or apical plasma membrane and how existing plasma membranes could rearrange 
to form a vascular lumen. However, in vivo studies are time-consuming and high-
cost. Also, the biology of animals, mostly mice[25], is different from humans and 
the rejection reaction could be a severe problem.  
Due to these complications, several methods that have been developed to 
generate microvasculature in vitro. The idea of prevascularization was first 
reported by Mikos et al. in 1993 [26], with the main concept being to incorporate 
endothelial cells into decellularized tissue or an ECM [27-30]. However, the 
network patterns of microvasculature were usually formed randomly and the 
diameters of the produced vessels were uncontrollable. Another strategy to 
generate blood vessels in vitro is to create lumen structures via microfluidics or 
bio-ink three-dimensional printing techniques[31-33]. Although a microvascular 
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network with desired design pattern could be formed, most of these techniques 
suffered from an unrealistic minimum lumen diameter (several hundred microns) 
or non-cylindrical shapes that are dissimilar to natural forming microvasculature in 
the body. 
With the advent of biopolymers, a fiber scaffold could be used to support 
and guide endothelial cells to generate a microvascular network in vitro. Currently, 
traditional techniques such as dry spinning, wet spinning, and electrospinning are 
employed to produce a variety of fibrous structures including suspended 
microfibers, fibrous monoliths, porous films, and nano-fibrous mats. However, the 
limitations on the accurate placement of fibers to predefined locations with 
controlled diameters have impeded the further advancement of these types of 
microvascular networks. Thus, developing a three-dimensional microvascular 
scaffold with a specific pattern and biomimetic diameter to provide temporary 
mechanical support and stimulate endothelial cell adhesion, growth and 
morphogenesis into a vessel would be beneficial. Our research group has 
developed a “Direct-write” method using a 3-Axis robotic dispensing system to 
fabricate suspended micron/sub-micron polymer fibers. The driving mechanism 
behind this process harnesses the surface tension of liquid bridges to promote the 
controlled thinning of a macroscale polymer solution filament into the desired 
microscale fibers. The advantage of this process is the ease of obtaining arrays of 
precisely-positioned fibers with controllable diameters in three-dimensional space. 
Several scaffold design criteria should be met: (1) The scaffold size and spatial 
position should be controlled within the microvascular scale. (2) The scaffold must 
5 
 
be capable of adhering and proliferating the endothelial cells. (3) The scaffold must 
be robust enough to remain during cell proliferation so as to allow a monolayer of 
endothelial cells to be formed and supported by ECM. (4) The scaffold should 
degrade in a reasonable time to develop the final capillary network.  
 
1.1 Purpose of the Study 
The overall goal of this project was to develop a model for the construction 
of a precisely positioned, three-dimensional, suspended biopolymer scaffold with 
controlled diameters and a proof-of-concept of a physiological microvascular 
networks in vitro. The studies presented in this work focus on: (1) direct-writing the 
three-dimensional oriented biopolymer scaffold with microvascular-scale 
diameters by using a 3-Axis robotic dispensing system; (2) developing and 
validating an empirical model of the direct-write process based on a design of 
experiment, characterization, and dimensional analysis; (3) determining a recipe 
for seeding the Human Dermal Microvascular Endothelial Cells (HDMECs) on the 
fabricated scaffold to form a confluent HDMECs monolayer; and (4) embedding 
the HDMECs-covered scaffold into the collagen hyrogel to form a vascularized 
sheet in order to demonstrate the conceptual “modular tissue”, which could be 
potentially assembled to bulk tissue. 
 
1.2 Specific Aims 
The specific aims for this project are: 
6 
 
Specific Aim 1: To fabricate precisely-positioned, suspended micro-fibers 
and branch structures with microvascular-scale diameters. These micro-fibers and 
branch structures will be fabricated from a variety of biodegradable polymers via 
the direct-write technique. 
Specific Aim 2: To generate and validate an empirical dimensionless 
model of the direct-write process. Gelatin will be used to perform a design of 
experiment and characterization for the empirical dimensionless model generation. 
Poly(Lactic-co-glycolic acid) (PLGA), gelatin/PLGA composites, Polylactic acid 
(PLA), and Polylactic acid- Polyethylene glycol (PLA-PEG) copolymer will be used 
to validate the empirical dimensionless model.  
Specific Aim 3: To seed the endothelial cells on the selected scaffold by 
following the scaffold-covering strategy. HDMECs will be used to grow a confluent 
monolayer on the surface of the scaffold. The monolayer should spread along the 
axis and around the circumference of the fiber. 
Specific Aim 4: To encapsulate the cell-covered scaffold into ECM and 
continue to culture to obtain the vascularized sheet. Type I collagen from rat tail 
will be used as the ECM. The scaffold degradation and Cell-Scaffold-ECM 
interaction will be evaluated through various imaging techniques. 
 
1.3 Significance of the Study 
This project aims to generate a conceptual solution for creating a three-
dimensional microvascular network in vitro. In this project, a biodegradable 
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microvascular scaffold will be developed and fabricated by integrating direct-write 
technique through a 3-axis robotic dispensing system. The fabrication will be 
characterized and an empirical model will be generated to predict the scaffold 
diameters. Instead of using human umbilical vein endothelial cells (HUVECs) in 
the most reported prevascularization research, Human Dermal Microvascular 
Endothelial Cells (HDMECs) will be chosen because they have a real common 
origin with human blood and lymphatic capillaries. HDMECs will be seeded on the 
scaffold, and a confluent monolayer will be formed on the surface of the scaffold. 
ECM will be added to support the endothelial cells and form a cell-viable, flexible, 
and free-standing vascularized sheet, which could be potentially assembled to a 
three-dimensional microvascular network. To date, the combination of using the 
direct-write technique to fabricate biopolymer scaffold and create a microvascular 





CHAPTER 2:  BACKGROUND 
2.1 Overview of the Microcirculation System 
Microcirculation is one of the most essential components in the human 
circulation system, and 84% of systemic circulation occurs here. The primary 
function of the microcirculation system is to transport  nutrients to the tissues and 
removal of cell excreta[34, 35]. The microcirculation system is ubiquitously 
distributed in our bodies, and the peripheral circulation has about 10 billion 
capillaries. The estimated surface area of these capillaries may cover 1/8 of a 
standard US football field (500 to 700 m2). Most of the functional live cells of the 
body are in about 20 to 30 micrometers away from a capillary[34]. Cells too distant 
(> ~200µm) from capillary would not survive and proliferate due to the lack of the 
supply of oxygen and nutrients[36]. 
2.1.1 Structure of the Capillary System 
In general, the capillary system consists of three primary components: 1) 
Arterioles – artery will form 6 to 8 branches after entering an organ and become 
smaller, which generally have internal diameters of 20 to 40 micrometers. 2) 
Capillary – arterioles further branch 2 to 5 times, leading to only 5 to 10 
micrometers at their ends. 3) Venules – capillaries converge together to form small 
vessels before exiting an organ and connecting to the vein. The venules are 
usually smaller than arterioles in diameter. The typical arrangement of the capillary 
bed is shown in Figure 2.1. The arterioles have a robust muscular coat, and they 
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are expandable and contractile thus they can control the blood flow into each tissue. 
The terminal arterioles, also known as metarterioles are encircled by smooth 
muscle fibers at the intermittent points. The muscular coat is not continuous in 
metarterioles. The capillaries also encompassed by smooth muscle fibers just like 
metarterioles. This configuration is defined as precapillary sphincter, and it can 
control the entrance of the capillary. Although the venules are not very muscular 
like arterioles, they can still expense and contract due to lower pressure in 
venules[34, 35]. 
 
Figure 2. 1 Illustration of the structure of the capillary bed. Source:[37] 
 
2.1.2 Structure of the Vessel Wall 
Arterioles are the smallest arteries, and their structures are often simple. 
Arterioles have a poorly-defined tunica externa. In some larger arterioles, the 
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tunica media is consists of one or two layers smooth muscles cells with thickness 
~20µm[35]. In contrast, the tunica of the smaller arterioles has scattered smooth 
muscle cells with incomplete cell layer. Venules have similar structures as 
arterioles, generally with no elastic tissue and less smooth muscles and fibrous 
tissue. The capillary wall is constructed of single-layer endothelial cells, and the 
endothelial cells are surrounded by a basement membrane on the outside. 
Capillaries are extremely thin (~0.5 micrometers) and permeable, thus the 
nutrients and wastes can be exchanged between circulation systems and the 
cells[34]. The summary and comparison of these three vessels in microcirculation 
is shown in Table 2.1[38]. 






2.1.3 Structure of the Capillary Wall 
As now we know endothelial cell layer exists in all the microcirculation 
vessels, a further study of the capillary wall could help us to understand the 
structure and mechanism for the tissue engineering better. Figure 2.2 is an 
illustration of the structure of the capillary wall. Small “slit pores” with average width 
about 6 to 7 nanometers could be found between two adjacent endothelial cells, 
known as intercellular cleft. The cleft connects endothelial cells together by a tiny 
protein bridge, and the thin slit could make sure fluid can freely flow through it. The 
many small caves in endothelial cells are plasmalemmal vesicles. The real 
functions of these caves are still not clear, and some studies show they  involve 
transporting nutrients molecules across endothelial cells’ membrane[34]. 
 
Figure 2. 2 Illustration of the structure of the capillary wall. Source: [34] 
In general, there are three types of capillaries according to the degree of 
permeability caused by different structures: 1) Continuous Capillaries – Most 
common capillaries that could found in muscle and skin. The intercellular clefts are 
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very small to ensure the least permeability. 2) Fenestrated capillaries – Often found 
in kidneys and small intestines where a high rate of exchange is needed. The 
relatively large pores make sure small molecules could pass through the 
membrane. 3) Sinusoidal capillary – Specifically found in liver, bone marrow, and 
spleen which are usually loose structures. The intercellular clefts are wide enough 
to pass through the entire cells. All three types of capillaries are shown in Figure 
2.3. The blood-brain barrier is an exception that the endothelial cells have no 
intercellular clefts and tight junctions are encircled by the whole capillary. Only a 
few selected vital molecules could pass through the membrane.  
 
Figure 2. 3 Illustration of three structures of capillaries: continuous capillary, 
fenestrated capillary, and sinusoid capillary. Source: [37] 
 
2.1.4 Function of the Capillary System 
Instead of flowing continuously in the artery and vein, blood flows 
intermittently in the capillary system. The intermittent contraction of metarterioles 
and precapillary sphincters control the capillaries open and shut every few seconds 
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or minutes. The most important function of the capillary system is to exchange 
water, nutrients, and other substances between the blood and interstitial fluid, and 
the most efficient way to exchange is diffusion. Figure 2.4 is showing blood flows 
through the capillary’s lumen, and countless water molecules and dissolved 
nutrients diffuse in and out through the capillary wall. Different molecules may have 
different diffusion paths because of the molecules’ sizes, properties, and 
concentrations. Such as lipid-soluble molecules directly diffuse through the 
capillary wall, whereas water-soluble substances diffuse through the holes of the 
intercellular “pores” in the capillary’s membrane.  
 
Figure 2. 4 Diffusion of fluid molecules between the capillary and interstitial fluid 





2.1.5 Endothelial Cell 
As we discussed before, the endothelial cells are the most fundamental 
component of the microcirculation system. They differ in structures and functions 
according to their ubiquitousness in different vascular locations and 
microenvironments[39, 40]. We could briefly classify endothelial cells into two 
categories: (1) Large vessels endothelial cells, and (2) Microvascular endothelial 
cells. Microvascular endothelial cells will be discussed in this work since we are 
trying to engineer the capillary network. One significant property of the 
microvascular endothelial cell is that they are highly active and intimately involved 
in numerous physiological processes. The list of the common commercially -
available endothelial cell is shown in Table 2.2. 
Table 2. 2  List of common commercially-available endothelial cells. Source:[41] 





Umbilical vein and 
artery, the aorta, the 
coronary artery, and 
the pulmonary artery 
Human Umbilical Vein Endothelial Cells 
(HUVEC),  
Human Umbilical Artery Endothelial Cells 
(HUAEC),  
Human Aortic Endothelial Cells (HAoEC), 
Human Coronary Artery Endothelial Cells 
(HCAEC)  








cardiac and uterine 
tissues 
Human Dermal Microvascular (HDMEC),  
Human Cardiac Microvascular Endothelial 
Cells (HCMEC),  
Human Pulmonary Microvascular 
Endothelial Cells (HPMEC),  




2.2. Extracellular Matrix 
Extracellular matrix (ECM) are ubiquitous noncellular components that 
could be found in almost all the tissues and organs. The ECM not only acts as a 
three-dimensional structural scaffold for cells, but also functions as an adhesive 
substrate, presents, sequesters, and stores growth factors, senses and transduces 
mechanical signal, and serves as signals for morphogenesis and differentiation[42, 
43]. Fundamentally, the ECM is composed of water and various macromolecules. 
Those macromolecules have been classified into two main groups by composition: 
Proteoglycans and Fibrous proteins [44, 45]. More than 30 different proteoglycans 
are known in humans, most of which are composed of glycosaminoglycans 
(unbranched polysaccharide chains) that are covalently linked to a specific core 
protein. According to their core protein, the proteoglycans could be classified as 
three groups: Modular proteoglycans, Small leucine-rich proteoglycans (SLRPs), 
and Cell-surface proteoglycans (Figure 2.5) [46]. The formed glycosaminoglycans 
hydrogel fill the majority of the extracellular interstitial space. Recently studies 
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suggest that proteoglycans play a prominent role in a wide variety of functions, 
such as buffering, hydration, signaling, resisting compressive force, and binding 
growth factors[45, 47, 48].  
Fibrous proteins could be classified as collagens, fibronectins, elastins, and 
laminins(Figure 2.5) [45, 49]. Among those, collagens are the most common 
fibrous proteins found in the ECM, and more than 28 different types of collagen 
have been identified in the human body so far. Collagen could provide tensile 
strength, regulate cell adhesion, and direct tissue development[43]. A typical 
collagen molecule has a complex hierarchical structure that contains a signature 
triple-helix structure (300 nm in length and 1.5 nm in diameter). The collagen 
molecules could form fibrils and networks depending on the types of collagen. 
Type I, II, III, V, and XI could self-assemble into fibrils that can resist shear, tensile, 
and pressure force, whereas type IV, VIII, and X could form networks which are 
incorporated into the basement membrane[47].  
Fibronectin is another important non-collagenous fibrous protein. The 
fibronectin molecules are usually composed of multiple chains, each encoded by 
single genes. Fibronectin could be stretched many folds over its resting length by 
cellular traction force, and it could also direct the organization of the interstitial 
ECM[45, 50]. In addition, the adhesive Arg-Gly-Asp (RGD) sequence could be 
found in the hydrophilic loop of fibronectin. Thus, fibronectin could also act as an 
adhesive substrate for cell and other matrix proteins due to the fact that RGD 
sequences are critical for recognition and binding to many integrins [43]. 
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Recently studies suggest that ECM play an essential role in both 
angiogenesis and vasculogenesis. During the blood vessel generation process, 
the endothelial cells migrate, proliferate, and eventually form the lumen structure 
in the ECM[51]. Researchers have proved that integrin receptors of the ECM play 
a critical role in regulating the cell shape through the change in the cytoskeleton 
and forming the lumen shape via the difference in the cell-cell interactions[51, 52]. 
Several in-vitro studies have demonstrated that the endothelial cells could attach 
to both collagen Type I hydrogels and basement membrane MatrigelTM and 
subsequently migrate and align to generate capillary-like network[53, 54]. 
 
Figure 2. 5 Examples of common proteoglycans and fibrous proteins. Source: [45] 
 
2.3 Biopolymers 
Typically, biomaterials can be classified into three groups: ceramics, metals, 
and biopolymers[55]. Ceramic and metal scaffolds are predominantly used in 
orthopedic applications and thus will not be covered in this dissertation. However, 
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biopolymers have been implemented extensively as microvascular scaffold 
materials due to their excellent biocompatibility, biodegradability, and ease of 
processing characteristics. Based on the chemical structure and origin, 
biopolymers can be further divided into three groups: (1) Natural biopolymers, (2) 
Synthetic biopolymers, and (3) Composites. When considering which type of 
biopolymer to use, there are several chemical and physical properties that must 
be considered, beyond the typical biocompatibility and toxicity of the material, such 
as the material’s mechanical properties, biodegradability, and processability 
(Table 2.3 ), in addition to its ability to promote cell adherence and proliferation.  






















Natural       
Collagen 40 70 202-224 37-39 0.002-0.2 - 
Gelatin 50-70 25-85 0.66 62.5 0.002-0.03 - 
Silk 178 192-203 16-20 5.29-5.79 1.5-14.8 - 
Alginate 3-113 >300 31-37 11-17 - - 
Chitosan 156-170 99-131 82-166 5-8 0.002-0.007 - 
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Synthetic      
PGA 35-40 225-230 60-99.7 1.5-20 6-7 6-12 
PLLA 40-70 130-180 15 -150 3-10 2.7-4.14 24-60 
PDLLA 55-60 - 27.6-50 2-10 1-3.45 ~ 12 
PLGA 45-55 - 41-55.2 2-10 1-4.34 1-6 
PCL -65-60 58-63 20.7-40 300-1000 0.21-0.44 >24 
a PGA, poly(glycolic acid); PLLA, poly(L-lactic acid); PDLLA, Poly(D-lactic acid); PLGA, 
poly(lactic-co-glycolic acid); PCL, Poly(ε-caprolactone). 
 
2.3.1 Natural Biopolymers 
Natural biopolymers are usually produced from plants or animals, and can 
even be derived from microbial systems. Natural biopolymers have inherent 
bioactivity present such as receptor binding ligands for cells. For example, Fittkau 
et al. demonstrated the ability of biomimetic peptides, such as RGD, to selectively 
affect adhesion and migration of human microvascular endothelial cells on 
polyethylene glycol (PEG) surfaces[60]. In addition, materials from naturally 
derived origins increase the potential for the biopolymers to have similar chemical 
and/or physical characteristics as ECM components, which, in turn, may not induce 
a chronic inflammatory or immunological response or be toxic to the cells, which is 
often found in synthetic biopolymers[61]. Natural biopolymers can be recognized 
by the biological environment and channeled into metabolic degradation by 
undergoing enzymatic degradation through cleavage of the enzyme-sensitive 
20 
 
bonds, and eventually lead to erosion of the biopolymer[62]. In specific applications 
using a sacrificial scaffold, the degradation rate of the natural biopolymers can be 
accelerated by increasing the concentration of the enzymes[63]. Conversely, the 
degradation rate can be reduced by cross-linking[64] the biopolymer in order to 
avoid rapid degradation of the scaffold which could lead to the collapse of the 
developing microvascular network. Notwithstanding, natural biopolymers also 
present some disadvantages, such as slow processing and inherent batch-to-
batch variations[65].  
Natural biopolymers can be divided into four groups: (1) Polysaccharides; 
(2) Proteins; (3) Nucleic Acids; and, (4) Viruses (Figure 2.6) [66]. Nucleic Acids 
and viruses are rarely used in microvascular scaffold applications. However, 
proteins such as collagen, fibrin and silk fibroin, and polysaccharides such as 
chitosan and alginate are commonly used in vascular/microvascular development 
applications. 
 





As it has been introduced in the previous ECM section, collagen is the most 
abundant protein in mammals, and it is the major component of connective tissues, 
skin, bone, cartilage, and tendons. On the other hand, gelatin is a 
biomacromolecule derived through the partial hydrolysis of collagen, which 
converts the triple-helix structure into a coil structure due to cleavage of the 
hydrogen and covalent bonds (Figure 2.7). As a result, gelatin has similar 
biocompatibility and biodegradability characteristics to collagen, but collagen is 
water soluble.  
Collagen and gelatin have both been extensively used in tissue engineering 
because of their biocompatibility, weak antigenicity, high mechanical strength, and 
tunable biodegradability by controlling the degree of cross-linking[67]. Collagen 
and gelatin are commonly used as hydrogels in tissue engineering[68, 69]. They 
can also be processed into a variety of forms such as fleeces, sheets, tubes, fibers, 
powders, and injectable solutions[70]. Moreover, these two kinds of protein are 
popular natural biopolymers that are widely used to produce fibrous meshes and 




Figure 2. 7 Collagen triple helical molecules structure and gelatin coil structure. 
Source: [74] 
 
2.3.1.2 Silk fibroin 
Silk fibroin is a natural protein commonly produced by arthropods such as 
silkworms and spiders[86]. It exhibits a unique and useful combination of 
properties such as good biocompatibility, non-inflammatory, excellent mechanical 
strength, and low degradation rate. The silk fibroin molecule structure mainly 
consists of glycine, alanine, and serine. In general, scaffolds made from silk fibroin 
exhibit lower cell infiltration compared to other biopolymers. As a result, a number 
of techniques have been employed to improve cell attachment to the scaffold 
surface, including plasma treatment, cross-linking of the cell-binding domain, and 
even genetic engineering approaches [58]. Silk fibroin has been processed into 
films, nanofibers, membranes, mats, nets, hydrogels, and porous sponges using a 





Chitin commonly comes from the exoskeleton of arthropods and insects or 
the cell walls of fungi. Chitosan is a deacetylated derivative of chitin and a 
polysaccharide. Although they are both semi-crystalline biopolymers with good 
biocompatibility and biodegradability, chitosan attracts more attention because it 
is soluble in aqueous acidic media. Chitosan can easily interact with adhesion 
proteins, growth factors and other proteins since it has a linear monomeric 
bond[75]. The degradation of chitosan depends on its molecular weight, the degree 
of deacetylation, and the residual amount of acetyl content. Chemical modification, 
such as cross-linking, can be easily performed due to chitosan containing hydroxyl 
and amino moiety functional groups[76]. Wet spinning, electrospinning, 
microfluidic spinning, and solvent casting have been reported as processing 
techniques for fabricating chitin/chitosan into gels, films, particles, membranes, 
fibers, and scaffolds for a large number of different applications[77-80]. 
2.3.1.4 Alginate 
In addition to chitosan, alginate is another extensively studied natural 
polysaccharide that is typically extracted from brown algae (Phaeophyceae) by 
aqueous alkali solution treatment. Alginate is composed of guluronic acid (G-
Blocks) and mannuronic acid (M-Blocks)[81]. Different sources and production 
processes usually yield different lengths and sequential distribution of these blocks; 
thereby, directly affecting the molecular weight of alginate. The molecular weight 
can influence the degradation rate and mechanical properties of alginate-based 
biopolymers, for example, higher molecular weight alginate has a slower 
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degradation rate[82]. As a U.S. Food Drug Administration (FDA) approved polymer, 
alginate has many applications in the field of biomedicine due to its excellent 
biocompatibility, biodegradability, and low production cost. Alginate is highly 
suitable for hydrogels because it is hydrophilic, water-soluble and thickens in 
neutral conditions. Alginate has been widely used to encapsulate various cells and 
growth factors to fabricate cell-laden structures because it can be rapidly solidified 
in calcium chloride (CaCl2) solution[83, 84]. In addition, alginate can be processed 
into a fiber or fibrous structures by microfluidic spinning and other techniques [85-
89]. 
 
2.3.2 Synthetic Biopolymers 
The first resorbable synthetic biopolymer commercially produced was 
poly(glycolic acid) (PGA), which was developed by American Cyanamid Co. in 
1962 and commercialized in 1970. Since that time, a number of other resorbable 
synthetic biopolymers have been manufactured, including but not limited to 
poly(lactic acid) (PLA), poly(lactide-co-glycolide) (PLGA), poly(caprolactone) 
(PCL), etc. In synthetic biopolymer design and manufacture, the material’s 
properties such as mechanical properties, hydrophilicity, and even bioactivity can 
be customized by either chemical methods, such cross-linking with functional 
groups, or physical methods, such as copolymerization with specific monomeric 
units. The degradation rate can also be tuned by adjusting the monomer’s 
concentration for drug delivery and tissue engineering[90]. For example, poly 
(Lactide-co-Glycolide) (PLGA) is well known for shorter degradation times at 
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higher glycolic acid concentrations. Most of the synthetic biopolymers undergo 
hydrolytic degradation since they are usually associated with hydrolytically labile 
chemical bonds such as esters, orthoesters, anhydrides, carbonates, amides, 
urethanes, ureas, etc.[91]. The hydrolysis has its own downside such as the 
byproduct carbon dioxide, which can lower the local PH and result in cell and tissue 
necrosis. Another disadvantage of some synthetic biopolymers is they can be 
biologically inert and may not promote cell adhesion and proliferation when used 
as a scaffold. The cellular interaction with synthetic biopolymer scaffolds have 
been shown to be improved by both physical and chemical methods, including 
plasma treatment, covalent tethering of functional groups and augmentation with 
bioactive molecules, such as gelatin and fibronectin[92, 93].  
Synthetic biopolymers can be roughly divided into aliphatic polyesters, 
poly(amino acids), polycarbonates, and others based on their chemical structures 
(Figure 2.8). Among them, aliphatic polyesters such as poly(lactic acid) (PLA), 
poly (Lactide-co-Glycolide) (PLGA), and poly(ε-caprolactone) (PCL) have been 
extensively investigated for vascular/microvascular applications. 
 




2.3.2.1 Poly(lactic acid) 
Poly(lactic acid) (PLA) is a hydrophobic thermoplastic polymer. The 
monomer lactic acid can be derived from an abundant number of natural, 
renewable feedstock such as starch, wood chips or sugarcane[94]. Lactic acid has 
two stereoisomerism forms: L-Lactide and D-Lactide. The polymerization of these 
monomers leads to three morphologically distinct polymers namely, poly(L-PLA) 
(PLLA), poly(D-PLA) (PDLA), and poly(D,L-PLA) (PDLLA). PLLA and PDLA are 
semi-crystalline polymers while PDLLA is amorphous due to the random 
distribution of L-and D-lactide units. Both the crystallinity and mechanical 
properties of PLA can be tuned based on its molecular weight and the 
stereochemical makeup of its backbone[95]. High molecular weight PLA is usually 
prepared by the ring-opening polymerization method[96]. PLA undergoes 
hydrolytic degradation by the bulk erosion mechanism with the random scission of 
the main backbone and is more hydrophobic and the degradation time is long (1-
5 years). In addition, the degradation byproduct lactic acid will also be broken down 
into water and carbon dioxide via the citric acid cycle[97]. PLA is widely used in 
many biomedical applications such as drug delivery or scaffolds for the 
regeneration of cardiac, nerve, and bone tissue as well as blood vessels[98-100]. 
In the case of fiber formation, PLA fibers have been fabricated via wet spinning, 






Poly(Lactide-co-Glycolide) (PLGA) was developed as a family of 
copolymers with different lactide and glycolide compositions. PLGA is also 
synthesized by means of a ring-opening co-polymerization of two different 
monomers, glycolic acid, and lactic acid, and both L- and DL- lactides have been 
used for the copolymerization process. Gilding et al. have shown that compositions 
in the 25 to 75% range for Poly(L-Lactide-co-Glycolide) and 0 to 70% for the Poly(DL-
Lactide-co-Glycolide) are amorphous[104]. PLGA has been shown to undergo bulk 
erosion through hydrolysis of the ester bonds, and the degradation rates are 
tunable by changing the ratio of PLA/PGA. Adding PGA into PLA will reduce the 
crystallinity of the copolymers, and therefore increase the degradation rate due to 
autocatalytic hydrolysis. For example, 50:50 Poly(DL-Lactide-co-Glycolide) 
degrades in 1-2 months, 75:25 Poly(DL-Lactide-co-Glycolide) in 4-5 months and 
85/15 Poly(DL-Lactide-co-Glycolide) in 5-6 months[105]. The degradation 
byproduct of PLGA is poly(α-hydroxy acids), which can cause local acidosis in the 
body[106]. PLGA has been approved by the Food and Drug Administration (FDA) 
for fiber-based scaffold applications, and various fiber formation techniques have 
been developed, such as direct writing, wet spinning, melt spinning, microfluidic 
spinning [107-109], and especially electrospinning methods [110-113].  
2.3.2.3 Poly(ε-caprolactone) 
Poly(ε-caprolactone) (PCL) is a semi-crystalline synthetic polyester that is 
prepared through a ring opening ε–caprolactone polymerization scheme[114]. PCL 
has a low melting temperature (58 to 63 C̊), and is solube in a wide range of 
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organic solvents. PCL degrades slowly (>2 years) compared to other biopolymers 
through the hydrolysis of its aliphatic ester linkages. The degradation rate can be 
tailored by copolymerization with other lactones or glycolides/lactides. The good 
biocompatibility, mechanical properties, and processability make PCL desirable for 
tissue engineering applications, and more than 1500 papers have been published 
in the last two decades describing PCL-based biopolymers being used in 
biomedical engineering applications. In the case of fiber formation, PCL has been 
extensively studied for use in 3D scaffolds for tissue engineering with micro/nano-
scale fibers being achieved through several techniques including direct writing, 
electrospinning, melt spinning, wet spinning and solvent casting [115-119]. 
Besides being used as single phase biopolymer, PCL is also a good base polymer 
for developing co-polymers or composites[120, 121]. 
 
2.3.3 Composites 
As mentioned in the previous section, each of these individual biomaterial 
groups, including natural biopolymers and synthetic biopolymers, have their 
specific advantages and disadvantages (Table 2.4). A biopolymer composite is 
made by combining at least two constituent materials to produce a more viable 
scaffold by taking advantage of each composed material, independently. Unlike 
copolymers that are comprised of multiple different constituents, the phases of the 
composite material remain separate, and they are mechanically separable in 
theory, which allows for the transfer of loads between the different materials. The 
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mechanical properties of composites can be tailored by carefully changing the 
volume fractions of the constituent materials[122].  
Table 2. 4 A general comparison of natural and synthetic biopolymers in the 
scaffolding structure  
Biopolymer Advantages Disadvantages 
Natural 
biopolymer 
▪ Excellent biocompatibility, less 
inflammatory or immunological 
reaction 
▪ Good cell attachment and signaling 
due to biologically active 
▪ Controlled enzymatic degradation 
with no harmful degradation 
product 
▪ Usually highly porous and water-
soluble, and easy to get hydrogel 
▪ Slow production with batch-to-
batch variation 
▪ May contain impurities or 
heavy metal  
▪ Mechanically weak 





▪ Good biocompatibility 
▪ Controlled hydrolytic degradation 
▪ Predictable and tunable chemical 
and physical properties, generally 
better mechanical performance 
▪ Large-scale production with batch-
to-batch uniformity 
▪ Lower cost with a long shelf life 
▪ Biologically inert with poor cell 
attachment due to the lack of 
intrinsic surface ligands 
▪ May induce toxic degradation 
products 





Extensive research has been performed in developing natural-natural, 
synthetic-synthetic and natural-synthetic biopolymer composites for fiber or fibrous 
scaffold fabrication. For example, several composite fibers or fibrous scaffolds 
have been fabricated using fibrin and collagen[123], alginate and water-soluble 
chitin [84], PLGA with collagen[124], PLGA with chitosan[125], PCL and 
starch[126], and even silk fibroin, PLGA, and collagen[127]. As mentioned above, 
one of the major advantages of generating composite materials is to tailor the 
mechanical and/or chemical properties of the structure. Specifically, Slivka et al. 
combined PGA and PLGA fibers to enhance the compressive modulus and yield 
strength of articular cartilage scaffolds [128]. Similarly, Hokugo et al. produced a 
fiber hybrid sponge, for guiding skin and cartilage tissue formation, consisting of 
fibrin and PGA to yield a higher compressive modulus [129]. Another use of 
composites is to increase the bioactivity of the synthetic biopolymer through the 
introduction of natural biopolymers. Norouzi et al. demonstrated that hybrid 
scaffolds for skin regeneration and wound dressing applications can be created 
via co-electrospinning PLGA and gelatin improved fibroblast adhesion and 
proliferation[130]. Besides the previously mentioned blend spinning techniques of 
co-electrospinning and co-microfluidic spinning[131], another method to produce 
a composite material is by spinning fibers directly onto an existing matrix. For 
instance, Jeong et al. electrospun PLGA fibers onto the surface of tubular collagen 
scaffolds for vascular graft construction to improve the mechanical strength of the 




2.4 Fiber Fabrication Techniques 
The utilization of biopolymers and the ability to controllably fabricate micron- 
and nano-sized fibers only recently appeared over the last few decades, which has 
opened the door for a wide variety of fiber-based tissue engineering approaches. 
Recently, several fiber-based fabrication techniques have been implemented to 
engineer 3D biomimetic tissue-like constructs with prescribed mechanical 
properties, topography and composition[132].  
For microvascular structure formation, there are two common strategies: 
The first is to seed the cells in or on a fibrous scaffold and build a microvascular 
structure in situ. The other approach is to seed the cells directly onto or into a 
biodegradable fiber or fibrous scaffold that provides temporary mechanical support 
and create the inner lumen by removing the sacrificial structure. Both approaches 
are highly dependent on the fiber fabrication technique selected, which precisely 
controls the structural, topographical, mechanical properties, and degradation 
rates. In particular, the structural and topographical properties of the fibrous 
scaffold have been found to be essential for cell distribution[133], and the 
mechanical properties and degradation rate of the sacrificial fibers affect the 
cellular interaction and lumen formation[134].  
We will introduce several existing methods for fabricating fibers from natural 
and synthetic biopolymers as well as composites while focusing on the current 
and/or potential application in the creation of microvascular structures. These fiber 
formation methods include (1) Electrospinning, (2) Microfluidic spinning, (3) Wet 




Electrospinning is a fiber spinning technique driven by a high-voltage, 
electrostatic field for drawing viscoelastic polymer fibers with diameters ranging 
from a few nanometers to few micrometers[135-138]. A typical electrospinning 
setup consists of a viscous polymer solution, a high voltage source (5-50 kV), a 
pumping system with a spinneret (e.g. a pipette tip), and a grounded metallic 
collector plate (e.g. metal screen, plate, or rotating mandrel) at an optimized 
distance from the pipette tip based on the particular setup (Figure 2.9)[137]. In the 
electrospinning process, the polymer solution is dispensed to the end of the 
spinneret to form a droplet due to surface tension. The electrostatic force opposes 
and eventually overcomes, the surface tension to eject a charged jet of the polymer 
solution from the spinneret tip. The solvent evaporates from the solution when the 
jet travels from the tip to the collector, eventually forming a continuous fibrous mat 
on the collector[137]. The polymer solution properties (i.e., viscosity, surface 
tension, and electrical conductivity), the flow rate, applied voltage and distance of 
spinneret from collector directly affect the microstructure of the fibrous mat [139]. 
In addition, fibrous mats with random oriented or aligned fibers can be controlled 




Figure 2. 9 Schematic diagram of set up of electrospinning [141]. 
Electrospinning is a versatile and relatively simple technique that can be 
used to process many biopolymers into fibers. In fact, electrospinning is one of the 
most commonly used scaffold fabrication techniques because it can easily produce 
a nanofibrous mat with an ECM-like architecture. You et al. constructed 
nanofibrous scaffolds from PGA, PLA, and PLGA and evaluated the 
biodegradation rate of these scaffolds[140]. Fioretta et al. investigated the impact 
of different fiber diameters (2, 5, 8, and 11 μm) in electrospun PCL scaffolds on 
endothelial colony forming cells (ECFCs) in comparison to mature human umbilical 
vein endothelial cells (HUVECs). The results suggested that the individual fiber 
diameters of the fibrous scaffold can determine cell phenotype[115].  
Some researchers have indicated that aligned electrospun ultrafine fibers 
can regulate cellular alignment and relevant functional expression. Dalton et al. 
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electrospun fibers with diameters of ~960 nm from blends of PEG and PCL and 
patterned them into aligned lines and seeded with fibroblasts. The seeded 
fibroblast morphology was observed to be affected by the fiber orientation[142]. 
Zhang et al. prepared hydrogel fibers with uniaxial alignment from aqueous 
solutions of natural polymers such as alginate, fibrin, gelatin, and hyaluronic acid 
using an electrospinning technique in combination with electrical and mechanical 
stretching. The internal alignment feature enhanced the mechanical properties of 
the hydrogel microfibers and induced HUVEC alignment[143]. The fiber 
topography was also shown to affect cell behavior. Santos et al. electrospun PCL 
nanofibrous meshes on fibronectin-coated PCL fibers (160 nm in diameters) for 
endothelial cell migration in bone tissue and discovered that the ECs expressed a 
more elongated phenotype when compared to the PCL fibers with no nanofiber 
mesh[144]. Ekaputra et al. utilized a dual electrospinning /electro-spraying setup 
to fabricate a scaffold containing PCL fibers, collagen, and a hyaluronic acid-based 
hydrogel. This multi-component design encouraged osteoblasts to penetrate the 
scaffold, rather than simply growing across its surface[145].  
With respect to vascular constructs, Xu et al. used a rotating collector to 
produce an aligned nanofibrous mat of poly(l-lactide-co-e-caprolactone) [P(LLA-
CL)] (75:25) copolymer with the average diameter of the aligned fibers being 550 
nm in order to create a scaffold for potential use as a blood vessel scaffold. Smooth 
muscle cells (SMCs) were seeded onto the scaffold, and SMC cytoskeletal 
proteins were found to align in the direction of the scaffold fibers[146]. Similarly, 
Zhu et al. employed a mandrel collector to fabricate porous fiber meshes of 
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macroscopically aligned PCL fibers with an average diameter of ~10 µm for 
vascular tissue engineering applications. Human umbilical artery smooth muscle 
cells and HUVECs were seeded and cultured on these scaffolds[147]. Zhou et al. 
fabricated aligned PLLA microfibers with an average fiber diameter of 1.6 µm by 
using a jet electrospinning method. Ellipse-shaped nano-pores were incorporated 
in situ onto individual fiber surfaces to form nano-topographical features by varying 
ambient humidity. A 7-day in vitro assessment of human vascular smooth muscle 
cells (vSMCs) cultured on these fibers indicated correlations with the nano-
roughness[102]. 
Recently, electrospun fiber-based scaffolds have been improved by 
incorporating other components to obtain a bioactive coating or hybrid scaffold. 
Kwon et al. co-electrospun poly(L-lactide-co-caprolactone) (PLCL) with type I 
collagen and demonstrated that HUVECs exhibited improved attachment on the 
scaffold relative to a collagen-free scaffold[148]. Jeong et al. co-cultured SMCs 
and ECs onto a similar hybrid scaffold composed of a porous collagen matrix and 
an electrospun fibrous PLGA layer for vascular graft applications [112]. Likewise, 
Barreto-Ortiz et al. electrospun microfibers (average diameter ~200 µm) composed 
of a fibrin-coated hydrogel mixed with alginate and demonstrated that these 
microfibers could be used to guide the stepwise formation of multicellular 





2.4.2 Microfluidic Spinning 
Microfluidic spinning, also known as co-axial flow spinning, is a fiber 
formation technique based on micro-fluid dynamics principles. A typical 
microfluidic spinning system is comprised of a central channel, which delivers the 
polymer solution (sample flow) into the main channel, and two side channels that 
deliver sheath flow around the sample flow (Figure 2.10)[132, 150]. Due to the 
laminar nature of the flow in the microfluidic channel, the interface between the 
sheath flows and sample flow remains stable and polymerization only occurs 
downstream by either UV light exposure, ionic or chemical crosslinking process or 
a solvent exchange method[150]. The fiber diameter and cross-sectional shape 
are tunable by changing the polymer solution viscosity, the ratio between the 
sample flow and sheath flow rates and the channel geometry[151, 152]. Fibers 




Figure 2. 10 Schematic diagram of set up of microfluidic spinning [150]. In this 
process, fiber solidification can be achieved by either a solvent method or non-
solvent method, including photopolymerization, ionic crosslinking, solvent 
exchanging and chemical crosslinking. 
 
One major advantage to this technique is that the sample flow can be 
loaded with cells, which can remain viable and functional because the microfluidic 
channels are usually short in length and the cells are only exposed to a high shear 
stress for a very short period of time. Despite numerous advantages offered by 
microfluidic spinning, there are downsides to this technique. For example, the short 
amount of time available to solidify the fibers limits the choice of materials. Until 
now, only a handful of biopolymers have been used to produce microfibers through 
this technique. In addition, the microchannel can easily clog, which significantly 
affects yield. In addition, the microfluid spinning technique lacks the ability to 
generate cylindrical shapes that are similar to in vivo environment. 
Nonetheless, microfluidic spinning is emerging as a promising method for 
producing continuous fibers from biopolymer solutions. Reviews on general tissue 
engineering applications of this technique are available elsewhere[66, 133, 150, 
154]. Additionally, several investigators have developed microfluidic spinning to 
develop models for better understanding of neuronal and cancer growth, which 
also have the potential for being used in the construction of microvascular 
structures. Specifically, Kang et al. employed a PDMS microfluidic platform to 
continuously generate alginate thin flat fibers (thickness < 10 µm) with engraved 
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grooved patterns that were used to align different cells, such as cortical neuronal 
cell and myoblast cells[87]. Similarly, Hwang et al. designed a PDMS-based 
microfluidic spinning device to produce PLGA microfibers with diameters ranging 
from 20 to 230 µm and demonstrated the ability to culture aligned L929 fibroblasts 
[108]. Wei et al. produced microfluidic-based cell-laden microfibers from UV-cross-
linkable methacrylated alginate and HUVECs and MG63 cells[155]. In another 
study, a collagen suspension of Hep-G2 and HUVECs hydrogel microfibers were 
processed into microfibers (diameter ~230µm) by Stato et al. via a double core-
shell type microfluidic device and confirmed the connection of the cells by 
cultivation[156]. 
For microvascular structure formation, Tung et al. fabricated microvascular 
scaffold composed of PLGA fibers using a PDMS replica mold. These PLGA fibers 
featured diameters ranging from 13-50 µm that were wrapped with HUVECs on 
both sides[157]. Daniele et al. utilized poly(ethylene glycol) dimethacrylate 
(PEGDMA) and gelatin to create a variety of microvascular structures, including 
microfibers, microtubes, coaxial microfibers, and triaxial microfibers[131]. In a 
more recent study, Tian et al. presented a gas-in water microfluidic method to 
fabricate alginate-based composite microfibers with “cavity knots” and assembled 
them into a 3D scaffold, in which HUVECs were cultured to create a vascular 
structure[158]. Cell-laden fibers can also be produced by microfluidic spinning 
technique. For example, Lee et al. used a microfluidic chip and a mixture of Human 
Iliac Vein Endothelial-78 cells (HIVE-78) and 2 wt.% alginate solution to generate 
hollow alginate cell-laden fibers. Then they embedded these cell-laden fibers into 
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hydrogels with smooth muscle cells and successfully cocultured these cells for 
seven days[159]. 
 
2.4.3. Wet Spinning 
Wet spinning is a non-solvent-induced, phase-inversion, fiber fabrication 
technique that can yield microfibers with a wide range of diameters[160]. A 
standard wet spinning setup includes an injection system (can be driven manually, 
gravitationally, or by a syringe pump), a reservoir for the polymeric solution, a 
spinneret and a coagulation bath (which must contain either a poor solvent or non-
solvent for the polymers)(Figure 2.11)[132, 161, 162]. During spinning, the 
polymeric solution is continuously injected into one or multiple coagulation baths 
and the long continuous filament solidifies due to the polymer and solvent/non-
solvent exchange[161]. Some improved wet spinning systems introduce a fiber 
collection component such as rotating mandrel to attain circumferentially oriented 




Figure 2. 11 Schematic diagram of set up of wet spinning [162] 
While wet spinning is not able to produce scaffolds with ultra-small sized 
fiber diameters, in general, like electrospinning and microfluidic spinning, the fiber 
diameter is still similarly controlled by the polymer viscosity, the injection rate and 
the spinneret size[165]. One advantage of wet spinning scaffolds is that they have 
larger pore sizes compared to those fabricated by electrospinning, which is 
favorable for cell adhesion and cellular penetration within the scaffold[116, 166]. 
Wet spinning can also incorporate of cells within the fibers just like microfluidic 
spinning. However, the cross-linking reagents must be cell friendly because the 
cell exposure time is much longer than microfluidic spinning.  
Wet spinning is a straightforward and very easy to set up, and it has the 
capability of high volume fiber production if multiple spinnerets are used. A variety 
of natural biopolymers, synthetic biopolymer, and the composites thereof have 
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been used to generate micron size fiber-based scaffolds[132, 133]. In the case of 
microvascular structure applications, Zhang et al. developed a new wet spinning 
system to fabricate oriented PCL microfiber scaffolds with the fiber diameter and 
porosity being controlled in the range of 7-27 µm and 68 to 82%, respectively. 
SMCs could grow in an oriented fashion along the fibers and infiltrate inside the 
scaffold[116]. Takei et al. extruded sodium alginate solution containing bovine 
carotid artery vascular endothelial cells (BECs) into CaCl2 solution and obtained 
microfibers. The BECs eventually migrated into the ambient collagen gel and self-
assembled into capillary-like structures[88]. Microvascular networks could also be 
created by wet spinning sacrificial microfibers. In a recent study, Lee et al. reported 
a sacrificial template-based strategy utilizing wet spun poly(N-isopropylacrylamide) 
(PNIPAM) fibers (diameters ranging from 3-55 µm) to produce 3D microvascular 
networks in cell-laden gelatin hydrogels. This capillary-like microvascular network 
allowed constant perfusion of the media and improved the viability of human 
neonatal dermal fibroblasts encapsulated within the gel[167]. 
 
2.4.4 Melt Spinning 
Melt spinning, sometimes called extrusion, is widely used for fiber formation 
in the polymer industry. In the standard process of melt spinning, a polymer is 
heated to its melting point and extruded through a micron-sized spinneret orifice 
and then directly solidified into continuous fibers by rapid cooling (Figure 2.12) 
[133]. In general, melt spinning tends to produce the largest diameter fibers (on 
the order of a few hundred microns) compared to the previously mentioned fiber 
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fabrication techniques. However, melt spun fibers with a diameter under 100 µm 
have also been reported[168]. The fibers’ diameter is affected by the polymer’s 
characteristic properties, size of the spinneret orifice, spinning temperature, and 
extrusion rate[169]. Melt spinning has a unique advantage in its ability to create 
controlled, complex cross-sections of the fibers. Star shape, fractal-like, grooved 
and even hollow fibers have been produced by melt spinning with special designed 
spinneret orifices [170-173]. Researchers have shown fibers with grooved cross-
sections assist in cells attaching and aligning themselves parallel to the direction 
of the grooves[171]. Associated results also support that the mechanical properties 
such as tensile strength and Young’s modulus are improved by melt spinning[101]. 
However, due to the spinning process requiring high temperatures, it is challenging 
to incorporate cells into the melt spinning fiber process like microfluidic spinning 
and wet spinning.  
 
Figure 2. 12 Schematic diagram of set up of melt spinning [133] 
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Melt spinning was first used to produce fibers in the textile industry and now 
it is an appeal in the creation of biopolymer fibers has grown recently in the tissue 
engineering arena. Park et al. utilized three customized spinnerets to produce PCL 
fibers with circular, triangular, and cruciform cross-section and the equivalent 
diameters of ~200 µm. They further showed the woven scaffolds composed of the 
fibers with noncircular cross-section significantly increased the proliferation of 
human osteosarcoma MG63 cells and decreased the degradation time[117]. Wu 
et al. assembled melt spun PGA-PLLA fibers into a non-woven scaffold and 
showed that human endothelial progenitor cells (EPC) have an inherent ability to 
assemble into a microvascular-like network[174]. Similarly, melt spun fibers were 
used as sacrificial fibers to create 3D microvascular networks. Specifically, Bellan 
et al. used cotton candy to fabricate sugar fibers and then developed a 3D 
perfusable microvascular network using the sugar fibers as sacrificial 
structures[134]. In a more recent study, Patrick et al. developed a 3D 
interconnected microvasculature in which the sacrificial fiber composed of PLA and 
tin(II) oxalate was melt spun with diameters of the composites fibers ranging from 
550 to 850 µm[175]. 
 
2.4.5 Direct Write/Solvent Casting 
Traditional solvent casting is a fiber manufacturing process that involves 
mixing of a solubilized polymer matrix and filler under continuous agitation through 
mechanical stirring, followed by casting and solvent evaporation or drying 
steps[176]. In this straightforward process, the polymer is first dissolved in an 
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appropriate volatile solvent or water, and then the polymer solution is cast on a 
substrate such as a flat surface or heated drum. The traditional process does not 
need special equipment and is very easy to implement, and thus, has become 
popular for biological applications. For example, Lieder et al. developed a protocol 
for solvent casting chitosan membranes and demonstrated that the mouse pre-
osteoblastic cell line MC3T3-E1 could be successfully attached for 24 days[78].  
Overall, the solvent casting method is an inherently slow process, but the 
concept itself offers potential when adapted to micro- and nano-scale applications 
using specialized equipment. Specifically, a technique known as direct write was 
recently developed to create a fiber-based scaffold for tissue engineering and 
microvascular network applications[177, 178]. A typical direct write setup includes 
a computer-controlled translation stage, a deposition nozzle, and a deposition 
substrate (Figure 2.13). Nain et al. and Berry et al. have produced polymer fibers 
with micro- and nanoscale diameters by directly ejecting polymer solution from a 
hollow capillary and then thinning into filaments by capitalizing on the surface 
tension-driven necking phenomenon, which like solvent casting leverages the 
solvent volatility to form fibers [179, 180]. Berry et al. further showed that the fiber 
diameter could be controlled by solution concentration, drawing rate, and fiber 
length[181]. They also demonstrated the ability to generate micron-sized fibers 
from a variety of biopolymers such as PCL, PLLA, PDLLA, and DL-PLGA[181]. 
Similarly, Vozzi et al. have utilized a pressure assisted micro-syringe to direct write 
PLGA scaffolds with feature sizes of 10-30µm[111]. Guo et al. have reported a 
robotic system to print various geometries such as filaments, towers, and freeform 
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circular spirals from PLA[182, 183]. In another study, Kullenberg et al. have 
employed a pressure-assisted micro-syringe (PAM) system to fabricate hexagonal 
scaffolds of PLGA fibers and discovered the optimized hexagonal scaffold size for 
neural cell adhesion[184]. Nain et al. have developed a Spinneret-Based Tunable 
Engineered Parameters (STEP) technique to construct aligned microfibers using 
both PLA and PLGA. They further investigated the effect of the scaffold 
morphology to the mouse C2C12 cellular behavior[185]. Similarly, Wang et al. 
fabricated suspended multilayer hierarchical nanofiber scaffold using STEP 
technique and seeded C2C12 mouse myoblasts on the scaffold[186]. 
 




The direct write technique offers more dimensional and textural control 
compared to other fiber spinning techniques. More recently, Berry et al. created 
microvascular scaffolds using the direct write technique and successfully seeded 
the fibers with HUVECs. These scaffolds were created as either individual fiber 
strands or with branched structures composed of suspended synthetic biopolymer 
(L-PLA, DL-PLA, PLGA (50:50 and 75:25) and PCL) microfibers with microvascular-
scale diameters (5-20 µm) and point-to-point orientation[118]. Direct write 
technique can also incorporate cells within the fibers and produce cell-laden fibers 
for microvascular structures. Gaetani et al. have used a bioprinting system and a 




In addition to the five previously mentioned fiber fabrication techniques, 
some other polymer fiber-based scaffold methodologies have been implemented 
to produce cellular scaffolds. Although these scaffolds are not all used for creating 
microvascular structures, these methodologies still hold promise for future 
applications. For example, Interfacial Polyelectrolyte Complexation(IPC) is a 
process whereby fibers and capsules are formed through interactions at the 
interface of oppositely charged polymers[187]. One significant advantage of the 
IPC process is the ability to encapsulate biological components such as cells, 
extracellular matrix proteins, growth factors, and plasmid DNA. Du et al. have 
developed a method to draw IPC fibers and encapsulate hepatic and endothelial 
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cells into the fibers to assemble endothelialized liver tissue constructs[188]. 
Human mesenchymal stem cells (hMSCs) encapsulated in IPC fibers made from 
alginate and water-soluble chitin polymers have been reported by Yim et al.[84]. 
Similarly, Lu et al. used a microfiber system to fabricate IPC fibers for human 
pluripotent stem cell (hPSC) encapsulation[189]. More recently, Lim et al. used the 
same polymers to generate 3D fibrous hydrogel cell-laden scaffolds for engineered 
follicular structures[190]. In general, the IPC technique requires a relatively simple 
setup; however, both the biopolymer selection available for this process and the 
working fiber diameter range is limited. 
Rotary Jet Spinning(RJS) is another reproducible technique for bulk nano-
/micro-fiber production. In this process, the polymer solution is ejected from the 
micron-sized orifice in a high-speed rotating reservoir, and nanoscale polymer 
fibers are solidified on the collector by solvent evaporation. Golecki et al. have 
fabricated PLA nanofibers with a diameter ranging from ~250 to 950 nm and 
revealed that fiber drying played an important role in determining nanofiber 
morphology[191]. In another study, Badrossamay et al. utilized PLA/chloroform 
solution to fabricated aligned 3D nanofiber structures with diameters ranging from 
50 to 3500 nm, and they further created anisotropic muscle with aligned and 
elongated myocytes and ordered myofibrils, based on the nanofibers[192].  
A variety of rarely utilized fiber formation techniques have also been 
reported for tissue engineering applications. Qiu et al. found that 
polyvinylpyrrolidone (PVP) could self-assemble into branched hollow fibers, which 
can potentially be applied to forming artificial blood vessels[193]. Wang et al. used 
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femtosecond laser ablation to fabricate pillared PLGA microvessels and observed 
that bovine endothelial cells adhered well and grew to surround each branch of the 
pillared microvessel network[194]. In recent research, Kalisky et al. have 
presented a method to produce microfibers (~50 µm) using a core-shell approach, 
composed of a calcium alginate shell and a cellularized type I collagen core. This 
approach can control fiber diameter and geometry, and it also allows cultured cells 
to distribute preferentially on the surface of the fiber and display a uniform cellular 
orientation[83]. 
A comparison of the biopolymer fabrication techniques is shown in Table 
2.5. The Summary of recent studies on microvascular structures using the different 
fiber fabrication techniques and cell types is shown in Table 2.6. 






▪ Multiple biopolymer choices 
▪ Ability to form nano-scale fibers 
▪ Volume production 
▪ Not suitable for cell 
encapsulation due to harsh 
process 
▪ Difficult to fabricate single fiber 
or spatially controlled structure 






▪ Ability to control fiber cross-
sectional shape and diameter 
▪ Tiny volume sample 
consumption 
▪ Suitable for cell encapsulation 
▪ Ability to get hollow or coaxial 
fibers 
▪ Complicated setup  
▪ Limited biopolymer choices 
▪ Microchannel clogging 
Wet spinning 
▪ Pre-controlled fiber diameter 
▪ Suitable for cell encapsulation 
▪ Unable to form nano-scale 
fibers 
▪ Difficult to get aligned fibers 
Melt spinning 
▪ Ability to control fiber cross-
sectional shape and diameter 
▪ Simple setup 
▪ Not suitable for cell 
encapsulation due to high 
temperature 
▪ Limited to large fiber diameters 
Solvent casting 
▪ Ease of fabrication without the 
need for specialized equipment  
▪ Limited biopolymer choices 
▪ Unable to control fiber 
alignment 
▪ Slow process 
▪ Limited to large fiber diameters 
Direct write 
▪ Ability to control fiber 
orientation and diameter 
▪ Ability to form nano-scale fibers 
▪ Suitable for cell encapsulation 
▪ Complicated setup (i.e. 
computer-controlled translation 
stage) 







▪ Suitable for cell encapsulation 
▪ Ability to get hollow or coaxial 
fibers 
▪ Limited biopolymer choices 




Table 2. 6 Summary of recent studies on microvascular structures using the 







Cell Type Ref. 
Electrospinning 
PCL 2-11 µm ECFCs, HUVECs [115] 
PCL-PLA 
copolymer 
550 nm SMCs [146] 
PCL 10 µm SMCs and HUVECs [147] 




10-25 µm HUVECs [143] 





120-520 nm HUVECs [148] 








PCL 160 nm HUVECs [144] 
PCL 1-2 µm Osteoblasts [145] 
PLGA ~ 10 µm HUVECs [195] 
Microfluidic 
spinning 
PLGA 20-230 µm L929 fibroblast [108] 
Alginate < 10 µm 
Cortical neuronal 
cell and myoblast 
cells 
[87] 
Chitosan 50-200 µm Fibroblast [80] 
Calciµm alginate 19 µm Fibroblast [85] 
Calciµm alginate 40-300 µm 
HepG2 and NIH 
3T3 
[86] 
PLGA 13-50 µm HUVECs [157] 
PEGDMA and 
gelatin  






~100 µm HUVECs [158] 
Alginate 40-220 µm HIVE-78， SMCs [159] 
Alginate ~450 µm 
HUVECs and MG63 
cells 
[155] 
Collagen ~230 µm HUVECs [156] 
Wet spinning 
PCL 7-27 µm SMCs [116] 
Sodiµm alginate 250-500 µm BECs [88] 




PNIPAM 3-55 µm Fibroblasts [167] 
Melt spinning 
PCL ~200 µm MG63 cells [117] 
PGA-PLLA - EPC [174] 
Collagen 200-300 µm - [70] 
Chitosan 286-352 µm VICs [79] 
Cotton sugar 20 µm - [134] 
PLA and tin(II) 
oxalate 












1-100 µm - [181] 
PLGA 10-30 µm - [111] 
PLA 80 µm - [182] 
PLGA 10-30 µm SH-SY5Y cell line [184] 
PLA and PLGA 50 to 500 nm 










PDLLA and PLGA 







































50 to 3500 
nm 
Myocytes [192] 
PVP ~5 μm - [193] 













CHAPTER 3: MATERIALS AND METHODS 
3.1 Overview  
In this chapter, the instrumentation and techniques used to fabricate 
precisely positioned, three-dimensional, suspended branched microvascular fiber 
scaffolds and form a confluent monolayer of Human Dermal Microvascular 
Endothelial Cells (HDMECs) on the scaffold are described. 
The schematic illustrating the formation of a microvascular network is 
shown in Figure 3.1. The fabrication process consisted of implementing a 3-Axis 
robotic dispensing system for creating a suspended, branched micro-fiber scaffold 
(Figure 3.1A). The direct-write system was able to predictably and repeatedly 
construct micro-fibers with microvascular-scale diameters (5 – 20 µm). An 
empirical model was generated based on the gelatin fiber characterization data to 
express micro-fiber diameter in terms of the direct-write system operational 
parameters and polymer solution properties. The empirical model was validated 
and tested by drawing fibers from various biopolymers, composites, and 
copolymers. Upon completion of the fabrication process, HDMECs were seeded 
on the scaffold and cultured for two days. The cells wrapped circumferentially 
around the scaffold and spread along the axial direction of the scaffold (Figure 
3.1B-C). The HDMECs-covered scaffold was subsequently cultured in a lab-
derived extracellular matrix (ECM) for an additional three days. The ultimate vision 
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is that the cells can attach to the ECM and maintain the lumen shape after the 
scaffold is degraded (Figure 3.1D). 
 
Figure 3. 1 Schematic illustrating of the concept of the formation of a microvascular 
network, and the cross-sectional images are inserted. A) Direct-write branched 
structure scaffold, B) seeded HDMECs on the surface of the scaffold in the media, 
C) HDMECs grew along the axis and around the circumference of the scaffold in 





3.2 Instrumentation and Equipment 
3.2.1 3-Axis Robotic Dispensing System 
The biopolymer micro-fibers were direct-written from an integrated 3-Axis 
robotic dispensing system (Nordson Corporation, Westlake, OH; Figure 3.2A-B). 
This system is composed by the following subsystems: (1) JR 2203N 3-Axis 
Desktop Robot with accessory JR C-Points software (Janome Sewing Machine 
Co., Tokyo, Japan). The X-Y-Z robot axis has an operational range of 200 by 200 
by 50 millimeters, respectively, with a positioning resolution of 0.005 mm for X- and 
Y- Axes and 0.0025 mm for the Z-Axis. The X- and Y- Axes can be operated from 
7 to 500 mm/second, and the Z-Axis can be operated from 2.5 to 250 mm/second; 
(2) Valvemate 7100 Dispensing Valve Controller (Nordson Corporation, Westlake, 
OH). It can adjust the valve open time from 0.001 to 99.9 seconds with 0.001 
second increment by programming; (3) EFD-741 MD Series MicroDot Dispense 
Valve (Nordson Corporation, Westlake, OH); (4) EFD Optimum Dispensing Tips 
(Nordson Corporation, Westlake, OH), the inner diameters are coded by hub colors 
(Red: 0.25 mm, Clear: 0.20 mm, Lavender: 0.15 mm, Yellow: 0.10 mm) (Figure 
3.2C); (5) USB Digital Microscope Camera (Microview, Guangzhou, China). (6) 
2F500-1W Feedback control heater (Cadet, Vancouver, WA); and (7) Customized 
Polycarbonate Thermal Enclosure. The heater and enclosure can be used to 




Figure 3. 2 Optical Images of 3-Axis robotic dispensing systems: A) Image of 3-
Axis robotic dispensing system housed inside an enclosure; B) Close up image of 
the dispensing valve with attached USB microscope for visualization; C) Image of 
EFD Optimum Dispensing Tips with four colors indicating four different inner 
diameters. 
3.2.1.1 Operation 
Turn on the computer, desk robot, and valve controller and adjust the air 
pressure to 15 psi. Launch the JR C-Points software to initialize the X-Y-Z Axes 
stage and then firmly mount the designed substrate on the X-Axis stage. The 
microscope camera was activated and focused on the needle, and the dispensing 
tip was manually positioned to the predefined initiation spot and while the Z-height 
was adjusted to find the optimum initial distance above the substrate by using 
“JOG” function (Figure 3.3A). Process parameters such as the  initiation and 
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termination X-Y coordinates of the fiber, dispensing tip lift height, dispensing tip 
travel velocity (feed rate), and dispense time were input into the JR C-Points 
software (Figure 3.3B) and then uploaded into the memory of 3-Axis robotic 
dispensing system by clicking “Sent C&T Data” button (Figure 3.3C) The Valve 
open time was manually input into the valve controller. After 3 mL of biopolymer 
solution is loaded into the pressurized barrel and purged to eliminate the trapped 
air, click the “Test Run” button (Figure 3.3C) to execute the automatic drawing 
process.  
 
Figure 3. 3 Graphic interface of JR C-Points software 
3.2.1.2 Cleaning and maintenance  
Leaving the polymer in the dispense valve overnight may cause congestion, 
thus a proper cleaning and maintenance process at the end of the day or before 
changing different polymer solutions is critical. The pressurized barrel and 
dispensing tips can be simply discarded. To thoroughly clean the polymer solution, 
the EFD-741 Dispense Valve was carefully disassembled into components by 
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following the manufacturer’s guidance (Figure 3.4). Firstly, all components were 
washed by running hot water (70 ̊C) through the components to remove large 
polymer solution residue. Then all parts except the rubber O-ring were immersed 
into a beaker of acetone and subjected to an ultrasonic bath for 30 minutes. 
Subsequently, deionized (DI) water was used to rinse all the parts and the parts 
were then dried by compressed air. Needle packing assembly and piston/needle 
assembly needed to be lubricated with Nye Lubricant #865 gel before being 
reinstalled.  
 
Figure 3. 4 Image of disassembling components of EFD 741 dispense valve  
 
3.2.2 Rheometer 
The viscosity of the biopolymer solutions was measured by rheometer 
(Physica MCR 300, Anton Paar, Austria; Figure 3.5). The principle of this 
rheometer is similar to a standard cone and plate viscometer, which applies shear 
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on a fluid between the rotating cone and the static plateto measure the rotational 
resistance exerted by the fluid. The viscosity is calculated by the software from the 
resistance torque. This rheometer can determine a viscosity curve over a broad 
range of shear rates. A column-shaped heated/refrigerated water bath and 
circulator was attached and employed to maintain the test temperature. 
 
Figure 3. 5 Image of Physica MCR 300 rheometer under testing 
Turn on the water bath and warm up the rheometer for least 15 minutes. 
Next, remove the cone and plate (the choosing cone is DG 26.7 with a  diameter 
= 1 mm and plate is TEZ 150P-C) from the protect box and add 10 mL biopolymer 
solution into the plate. Then, properly mount the cone and plate to the position. 
Launch the Physica RheoPlus software and input the sample name, test 
temperature (25 ̊C), cone and plate code, shear rate range (0.1 – 1000 1/s) and 
time interval (150 s). By clicking the “Start” button, the machine will automatically 
operate by first heating to the desired temperature and then increasing the cone 
rotation speed until it reached the maximum rotational resistance was reached. 
62 
 
The viscosity curve over different shear rate was plotted and saved to the computer. 
The rheometer was calibrated by the calibration standard fluid 5000 every month 
(Viscosity = 4930 mPa*s at 25 ̊C, Brookfield, Middleboro, MA; Figure 3.6).  
 
Figure 3. 6 The viscosity of standard fluid for calibration 
 
3.2.3 Du Nüoy-Paddy Surface Tension Measurement System 
The surface tension of the biopolymer solutions was measured by using the 
Du Nüoy-Paddy method. This method involves slowly lifting a rod from the surface 
of the solution. The force required to raise the rod from the solution’s surface is 
measured and related to the solution’s surface tension. The custom surface 
tension measurement system is shown in Figure 3.7. A glass rod (diameter = 3.2 
mm) was vertically attached to a linear actuator (Firgelli L12) which was fixed to 
height adjusted stand. A precise balance (Mettler, PM100) was positioned to make 
sure the glass rod is vertical to the center of the balance weighing platform. A 
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LabView VI was programmed to control the linear actuator expense and contract 
through an Arduino microcontroller (UNO). Two USB- cameras were also used to 
monitor and record the balance reading and the interface between the glass rod 
and the solution surface. 
 
Figure 3. 7 Image of custom Du Nüoy-Paddy surface tension measurement system. 
Inserted images showed the instant images of the balance reading and the 
interface between the glass rod and the surface of the solution 
A calibration was performed to make sure the LabView program and the 
Arduino microcontroller can control the linear actuator to expand and contract 
smoothly and accurately (Figure 3.8). 0.5 mL biopolymer solution was loaded into 
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a small glass sample bottle and positioned on the center of the balance weighting 
platform. The glass rod was dipped into biopolymer solution a few millimeters 
under the surface and the balance reading (M1) was recorded. The LabView 
program was employed to contract the linear actuator and record the balance 
reading (M2) when the glass rod was detached from the solution. The force (F) 
exerted on the rod due to the surface tension was calculated by:  
𝐹 = (𝑀1 − 𝑀2) ∗ 𝑔                                         (3-1) 




                                              (3-2) 
Where the p is the perimeter of the rod (p = 10.1 mm according to d = 3.2 mm), θ 
is the contact angle of the solution on the rod. The glass rod was chosen since all 




Figure 3. 8 Calibration of the linear actuator length corresponding the LabView 
Control position input 
 
3.2.4 Thermogravimetric Analyzer (TGA) 
Mass transfer coefficients of polymer solutions were measured by a 
thermogravimetric analyzer (SDT Q600 Simultaneous TGA/DSC, TA Instruments, 
New Castle, DE; Figure 3.9). The device can be used to measure high-precision 
weight change in the isothermal environment. 
 
Figure 3. 9 Image of TA SDT Q600 Simultaneous TGA/DSC. Inserted image 
shows the ceramic cup that holds the sample 
Turn on the machine and warm it up for 30 minutes. ~30 mg biopolymer 
solution was loaded into a ceramic cup after taring the empty cup. Launch the 
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QSeires software (Figure 3.10) and change the gas source to air. Set up the 
running sequences as below: (1) ramp 10.0 C̊/min to 25 ̊C; (2) isothermal for 120 
mins; (3) end of the cycle. Click “Run” button to start the sequences.  




                                       (3-3) 
where m(t) is the mass of the solution, A is the area of the solution/air interface 
(A~34.5 mm2 for standard TGA ceramic cup), and C(t) is the concentration of the 




                             (3-4) 
Where m(polymer) is the mass of polymer in the solution and ρ is the density of the 
solution. 
 




3.2.5 Fourier Transform Infrared Spectrometer (FT-IR) 
Polymer composites and copolymers were characterized by Spectrum 100 
Fourier Transform Infrared Spectrometer (PerkinElmer, Shelton, CT; Figure 3.11). 
The physical properties of polymer composites and copolymer are affected by the 
structure of the molecular chains. When infrared radiation passes through a 
polymer sample, some of the radiation is transmitted while some radiation is 
absorbed by the sample. The resulting spectrum of absorbed light represents a 
distinctive “fingerprint” of the molecular structure of the sample and reveals the 
information of intermolecular hydrogen bonding. 
 
Figure 3. 11 Image of PerkinElmer Spectrum 100 FT-IR spectrometer 
Sample films were prepared by casting 200 µL of 6% solution of each 
polymer composites and copolymer in 2, 2, 2-Trifluoroethanol and chloroform, 
respectively. Films were heated to 60 ̊C for 30 minutes and then left overnight at 
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room temperature to remove residual solvent. A background run is required to 
eliminate the H2O and CO2 band in the air. Unless otherwise noted, the spectrums 
were obtained with 32 scans per sample ranging from 4000 cm-1 to 650 cm-1 
(corresponding to wavelength from 2,500 nm to 15,000 nm).  
 
3.2.6 Nuclear Magnetic Resonance (NMR) Spectroscopy  
Copolymers were characterized by Varian Inova 400 MHz NMR (Agilent 
Technologies, Santa Clara, CA; Figure 3.12). The NMR study could identify the 
monomers’ ratios and the formation of new bonds.  
The target copolymer sample (20 mg) was dissolved in 500 µL CDCl3 in an 
NMR glass tube to form a slurry, which was then further sonicated to form a clear 
solution. The ejection, insertion, spinning, locking, and shimming were all 
controlled by VnmrJ Software. All 1HNMR spectra were acquired at frequencies of 
399.8 MHz and conducted at 25 ̊C. The chemical shifts are reported in  (ppm) 




Figure 3. 12 Image of Varian Inova 400 MHz NMR 
 
3.2.7 Scanning Electron Microscope (SEM) 
The LEO Supra 35 VP field-emission variable pressure scanning electron 
microscope (VPSEM) (Carl Zeiss, Oberochan, Germany; Figure 3.13A) and 
VEGA 3 tungsten thermionic emission scanning electron microscope (TESCAN, 
Brno, Czechia; Figure 3.13B) were both used to image and measure the 
biopolymer fibers and observe the cell grow on the scaffold and in the extracellular 
matrix. Despite the fact that the two SEMs have different electron sources, they 
both work in a vacuum environment (10-4 - 10-5 Pa) and have “Secondary Beam” 
detector. While the focused electron beam scans the sample, the secondary 
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electrons are collected and converted to represent topographical imagery on the 
screen.  
 
Figure 3. 13 Image of A) Carl Zeiss Supra 35 VP field-emission SEM. B) TESCAN 
VEGA 3 tungsten thermionic emission SEM  
For a non-conductive sample, electron accumulation within the sample, or 
"charging," often occurs, resulting in sample damage and reduced image quality. 
Before the samples were loaded into the SEM chamber, they were all sputter 
coated with a uniform thickness thin film of gold-palladium  by the benchtop SPI 
sputtering machine (Structure Probe, Inc., West Chester, PA; Figure 3.14) to 
improve conductivity. The sample was first placed in a chamber filled with Argon 
and then the chamber was vacuumed to ~80 millitorr. A visible discharge will be 
observed when the plasma current was set to ~18 milliampere. To deposit a 10 




Figure 3. 14 Image of SPI-module sputter coater 
The basic operations for these two SEMs are almost the same; however, 
the software is different and requires individual training for each. The sputter 
coated samples were attached to the desired stage platform with conductive 
carbon tape and loaded into the SEM chamber. Upon completion of the vacuum 
to reach the working air pressure, the working voltage and adjusted the working 
distance are manually selected before starting imaging. Unless otherwise noted, 
samples were observed with 2 – 10 KV working voltage and the working distance 
of 8 – 12 mm. 
 
3.2.8 Laser Cutting System 
Several custom acrylic frames used for fiber fabrication and cell culture 
were made by the LS1630 60-Watt CO2 laser cutting system (Boss Laser, LLC, 
Sanford, FL; Figure 3.15). The X-Y-Z axis stage has an operational volume of 75 
by 40 by 25 centimeters, respectively, with a positioning resolution of 0.025 
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millimeters along all three axes. A 250 cubic foot per minute (CFM) exhaust fan 
system is employed to vent the volatile fumes/particulates out of the laser cutting 
system enclosure and safely into the building HVAC fume extraction system. 
 
Figure 3. 15 Image of Boss LS1630 laser cutting system A) System body, B) Laser 
cut under the working  
The desired structure of interest was designed by SolidWorks and 
converted the 3D part file into 2D Adobe Illustrator file (.AI). The .AI file is imported 
into the RDWorks software. The laser head is positioned to the desired location 
over material to be cut and adjusted the laser beam to focus on the top surface. 
Set cutting speed and laser power with the Work tab. A power setting of 50% and 
cutting speed of 10 mm/s is utilized for cutting 3 mm thick acrylic. The cell culture 
frame with a recessed platform was achieved by two layers of operation (Figure 
3.16). The first layer was to create the recessed platform by out of focus laser scan 
mode; the second layer was to finally cut through the open window and boundary 




Figure 3. 16 Image of RDWorks software graphic interface with two layers of 
operations: Red (scan) and Black (cut). The insert image shows the 3D part file of 
the cell culture fiber frame with a recessed platform  
Table 3. 1 The operation parameters for cell culture fiber frame with a recessed 
platform 
Laser mode Focus (mm) Speed (mm/s) Power (%) 
Scan -10 300 40 
Cut 0 10 50 
 
3.2.9 Cell Culture Related Equipment 
Cell culture, subculture, and seeding were all performed in the Biomimetics 
& Tissue Engineering Laboratory at the University of Louisville (directed by Dr. 
74 
 
Patricia Soucy, BSL-2). The main aseptic area is supplied by 1300 Series A2 
Laminar-Flow Hood (Thermo Scientific, Waltham, MA; Figure 3.17) connected 
with an aspiration pump and waste bottle. Cells were cryopreserved in VWR 
CryoPro liquid nitrogen tank (Figure 3.18). Fisher Scientific ISOTEMP 210 Water 
Bath (Set to 37 ̊C, Figure 3.19) was used to thaw the cells or prewarm a necessary 
solution. Cells were incubated in the VWR CO2 incubator (Figure 3.20) with 
controlled temperature (37 ̊C), high relative humidity (~ 60%) and elevated CO2 
concentration (5.0%). 
 




Figure 3. 18 Image of VWR CryoPro liquid nitrogen tank and the insert image 
shows the drawers in a rack system inside of the tank  
 




Figure 3. 20 Image of VWR CO2 incubator 
While performing the cell subcultivation, the cell suspension was 
centrifuged by Allegra R Centrifuge (Beckman Coulter, Brea, CA; Figure 3.21) with 
GH-3.8 swinging bucket rotors at 220 G (980 RPM) for 5 minutes to increase the 
concentration or to wash off the reagent.  
 
Figure 3. 21 Image of Beckman Coulter Allegra 6R Centrifuge 
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Auto T4 Cellometer (Nexcelom Bioscience, Lawrence MA; Figure 3.22A) 
was utilized to determine the cell concentration and mean diameter of the cells to 
decide the seeding density. 20 µL of cell suspension was pipetted into the 
compatible cellometer disposable counting chambers (Figure 3.22B) and inserted 
into the cellometer. Select the cell types and click “Count” to get results (Figure 
3.22C).  
 
Figure 3. 22 Image of cell count: A) Nexcelom Auto T4 Cellometer, B) Nexcelom 
disposable counting chambers, and C) Accessory software graphic interface 




3.2.10 Epi-fluorescence Microscope 
A TE2000-U inverted microscope (Nikon, Shinagawa, Japan; Figure 3.23) 
with an X-Cite 120 fluorescence illumination system (Excelitas Technologies, 
Waltham, MA) and QIMAGING Retiga 2000R CCD camera (Teledyne, Surrey, 
Canada) was used to captured fluorescence images. This fluorescence 
microscope system was installed with three filters (1) Blue filter shows FITC and 
Alexa 488 (green colors); (2) Green filter shows Alexa Fluor 566 and Rhodamine 
(red colors), and (3) Violet filter shows DAPI and Alexa Fluor 350 (blue color). Cell 
samples need to be fixed first and then stained with different dyes prior to taking 
images. 10X, 20X, and 40X objectives were all used for capturing different 
magnification images.  
 
Figure 3. 23 Image of Nikon TE2000-U inverted microscope with an X-Cite 120 




3.2.11 Confocal Microscope  
An Eclipse Ti- A1R confocal microscope (Nikon, Shinagawa, Japan; Figure 
3.24) was employed to generate three-dimensional views of cells on the scaffold 
to evaluate if the cells could grow circumferentially around the fibers and if the 
neighboring cells can form cell-cell junctions. This confocal microscope system 
consisted of an inverted microscope and an A1R confocal laser system, which 
including a laser source, scanner controller, scan head, stage joystick, LED source, 
and a PC workstation. This confocal microscope system has three lasers excitation 
and corresponding filters: (1) 403.8 nm for DAPI (show blue color), (2) 487.8 nm 
for FITC (show green color), and (3) 561.6 nm for TxRed (show red color). 20X 
and 40X objective were used for different magnification images, and both 
objectives need to be immersed with oil. Accessory NIS Elements software could 
switch the objectives, select the different channels and filters, adjust the focal 
length and area, and change scanning speed. Unless otherwise noted, the pinhole 
was set to 1.5 AU, the laser power of 4 channels + TD were set to 5%, gain (high 
voltage) was adjusted between 60 to 120, and Offset was always set to 0. All z-
stacks were taken with a 0.2 µm step size. Similar to the fluorescence microscope, 
all the samples need to be fixed and stained with different dyes. However, due to 
the difficulty to transfer the scaffold onto standard microscope slides from a 
standard well plate, and the limited depth of field of objectives for suspended 
scaffolds, samples used for confocal imaging were all cultured and observed under 
two walls Chambered Cover Glass System (Cole-parmer, Vernon Hills, IL. Growth 
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area = 4.0 cm2 and the working volume = 1.5 mL; Figure 3.25). The ultra-thin (0.13 
mm) cover glasses on the bottom permit viewing of the cells on the suspended 
scaffolds. 
 
Figure 3. 24 Image of Nikon Eclipse Ti inverted microscope with A1R confocal 
laser system  
 





3.3.1 Biopolymer Solution Preparation  
The solvent selection is critical to fabricating the biopolymer fiber 
successfully by using the direct-write technique. According to the previous 
research in our group, the ideal solvent should meet the following two criterions: 
(1) the capability of the solvent to dissolve the polymer within a range of 
concentrations sufficient for direct-write; (2) moderate volatility as defined by a 
boiling point ranging from 60 to 140 ̊C. 
3.3.1.1 Gelatin, PLGA, and Composites’ Solution 
Although there are a variety of organic solvents including polar and non-
polar solvent that could successfully dissolve PLGA, gelatin is only dissolved in 
polar organic solvents such as 2,2,2-trifluoroethanol (TFE, BP = 78  ̊C), 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, BP = 58.2  ̊C), and acetic acid (AA, BP = 
118  ̊C) because it has strong polarity [196]. Thus, TFE and acetic acid were 





Figure 3. 26 Image of gelatin and PLGA and their composites solution in TFE 
 
Gelatin Type A from porcine skin (gel strength 300), 2,2,2-trifluoroethanol, 
ReagentPlus® grade, ≥99%), and acetic acid (≥99%) were all purchased from 
Sigma-Aldrich (St. Louis, MO). 50:50 DL-PLGA was purchased from Lactel 
Absorbable Polymers (Birmingham, AL). Gelatin solutions were produced by 
dissolving powder gelatin into AA or TFE; PLGA solutions were produced by 
dissolving granular PLGA in TFE; Gelatin/PLGA composite solutions were 
produced by physically mixing the gelatin and PLGA at a weight ratio of 70:30 and 
50:50 into TFE and maintained the whole concentration. All the solutions were 
vortex stirred for 3 minutes for pre-mix and followed by magnetic stir for 6 hours at 
room temperature. All the solutions were confirmed complete dissolution by 
inspected homogeneity and optical clarity after stirring. The solution remained 




3.3.1.2 PLA and PLA-PEG Copolymer’s solution 
Polylactic acid (PLA, 3001D, melt flow index of 1.1@ 210 C̊) and 
Polyethylene glycol (PEG, molecular weight 1000) were kindly supplied by Dr. 
Kunal Kate. Chloroform (≥99.8%) was purchased from Sigma-Aldrich (St. Louis, 
MO). PLA-PEG (50:50) and PLA-PEG (90:10) were previously synthesized by Dr. 
Kunal. PLA-PEG copolymers were synthesized by reacting the different ratio 
components (Table 3.2) in a three-neck glass reactor at 205 ̊C with stirring under 
a nitrogen atmosphere for 4 hours. The copolymer synthesis setup is shown in 
Figure 3.27. The resulting copolymer was cooled at room temperature and stored 
under moisture-free conditions. A home blender was used to ground the copolymer 





Figure 3. 27 Image of PLA-PEG copolymer synthesis setup 
 
Table 3. 2 Copolymer synthesis component mass ratio 
Copolymers PLA (g) PEG (g) 
PLA-PEG (75:25) 112.5 37.5 
PLA-PEG (70:30) 105 45 




Some non-polar organic solvents such as chlorobenzene (BP = 131 C̊), 1,2-
dichloroethane (BP =84 ̊C), acetone (BP = 57 ̊C), and chloroform (BP= 61 ̊C) were 
trialed to dissolve PLA and copolymers. All the solutions were vortex stirred for 3 
minutes for pre-mix and followed by ultrasonication for 3 hours at room 
temperature. Those solvents that could dissolve the polymer and copolymers at a 
concentration larger than 20% were chosen to draw micro-fibers.  
 
3.3.2 Scaffold Fabrication 
3.3.2.1 Fabrication of Single Suspended Fiber  
During the single suspended fiber fabrication process (Figure 3.28), the 
polymer solution was expelled to form a polymer droplet that makes contact with 
the substrate. The dispensing tip with polymer droplet then immediately was lifted 
1 mm and laterally translated with a constant traveling velocity to the predefined 
termination location on the other side of the substrate. The polymer droplet thinned 
and elongated to form a filament by surface tension driven necking as defined by 
the capillary drying process. Finally, the polymer solution was expelled again, and 




Figure 3. 28 Schematic illustrating (top) and real images (bottom) of the direct-
writing process. A) The polymer solution was expelled and contacted with the 
substrate. B) The dispensing tip was translated to a predefined point while the 
polymer filament undergoes surface tension driven necking. C) The polymer 
solution was expelled again to establish the ending contact point. 
3.3.2.2 Initial Polymer Drop Size and Needle-to-Substrate Gap 
The initial polymer drop size and the needle-to-substrate gap was 
determined experimentally by using USB-camera to capture and measure the 
resulting polymer drop images. Four different polymer solution drops were expelled 
under different valve open time: 0.02 s, 0.05 s, 0.1 s, and 0.5 s. The needle-to-
substrate gap was adjusted from 0 to 600 µm.  
3.3.2.3 Fabrication of Branched Structure 
The branch structure was fabricated as Figure 3.29. First, a single 
suspended fiber was fabricated across an acrylic frame (Figure 3.29A). Then, 
another fiber was drawn over top of the first fiber and lowered 2 mm to attach the 
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two fibers (Figure 3.29B-C). Finally, the needle was lifted and translated to the 
ending point to finish the structure construction (Figure 3.29D). The attachment of 
the two fibers was in a very short period (~1 second) so that both fibers still possess 
some solvent to promote the adhesion between the two fibers. 
 
Figure 3. 29 Schematic illustrating and real images of the fabrication of the 
branched structure  
 
3.3.3 Empirical Model Generation 
3.3.3.1 Theoretical Model 
A direct-written fiber is created by thinning and elongation from the bulk 
polymer solution, thus, understanding the polymer solution rheological properties 
is essential to the capillary thinning process. McKinley et al. developed an early 
model and showed that the filament would thin until capillary breakup when the 








𝑡                                          (3-5) 
Where D(t) is the diameter of polymer filament, D1 is the initial diameter of the 
polymer filament, X is a constant which determined to be 0.7127 and 1 by two 
different groups[198, 199], σ is the surface tension, η is the Newtonian viscosity, 
and t is the filament formation time. This model illustrates the relationship between 
the final polymer fiber diameter, the physical properties of the polymer, and 
operation time. However, the high volatility for the solvent of the polymer solution 
has not been considered. 
Tripathi et al. further proposed a theory that introduces the evaporation rate 
of the solvent into the model[200]. For a Newtonian solution, the equilibrium fiber 
diameter 𝐷∞ is given as below: 
𝐷∞ = 𝐷1 𝑒
−0.035/𝑃                                       (3-6) 
𝑃 =  
𝜂𝜒
𝜎
                                                    (3-7) 
Where P is defined as a dimensionless Processability parameter and χ is the 
evaporation rate, also known as polymer solution’s mass transfer coefficient. The 
model clearly shows that the high viscosity and high volatility will resist the thinning 
process while the surface tension will induce the thinning process.  
All the above models are established based on a simple polymer thinning 
process with constant length and zero velocity, but the direct-writing process has 
the ability to run at a different velocity and different length. The polymer fiber 
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formation affected by an increased number of variables; thus, the Processability 
parameter model should be augmented with additional dimensionless parameters 
to solve this problem. According to the Buckingham Pi theorem, given a relation 
among n parameters of the form: 
g(q1, q2, ···, qn) = 0                                     (3-8) 
The n parameters may be grouped into n – m independent dimensionless ratios, 
or Π parameters, expressible in function form by:  
G(Π1, Π2, ···, Πn-m) = 0                                 (3-9) 
Which m is usually equal to a minimum number of independent dimensions 
required to specify the dimensions of all the parameters.  
Carefully inspecting the direct-writing process described in Figure. 3.28, 
one dependent variable (fiber diameter, 𝐷∞) and five independent variables are 
involved: the polymer solution viscosity (η), polymer solution surface tension (σ), 
mass transfer coefficient (χ), feed rate (U), and fiber length (L). MLt (mass, length, 
and time) was selected as fundamental dimensions set. Thus, this dimensional 
analysis could be grouped into three dimensionless parameters (6-3=3).  
Except for the Processability parameter, two additional dimensionless 
parameters were introduced to the model to define the fiber drawing process: 




                                                       (3-10) 
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𝛬 =  
𝐿
𝐷0
                                                        (3-11) 
Where U is drawing velocity (feed rate) and D0 is the initial diameter of the polymer 
droplet.  
3.3.3.2 Design of Experiment  
The design of experiments was conducted by using Minitab with two 
important aims. The first aim was to investigate the influences of the four factors 
(solution concentration, feed rate, the inner diameter of the needle (ID) and fiber 
length) on the yield of the fiber. The second aim was to analyze the effect of the 
P- Ca - Λ dimensionless system on the diameter of the direct drawing fiber and 
further decide the optimal process parameters for to generate biopolymer fibers 
with diameters within microvascular range (5 - 20 µm). The experiment design with 
levels of factors is shown in Table 3.3.  




A, Concentration (wt.%) 3 15, 16, 17 
B, Feed Rate (mm/s) 3 100, 200, 300 
C, Needle ID (mm) 4 0.10, 0.15, 0.20, 0.25 




3.3.3.3 Model Generation 
The physical properties of the gelatin solution, such as viscosity, surface 
tension, and evaporation rate, were measured by the previously described 
methods in section 3.2. Three dimensionless parameters--Processability 
parameter (P), Capillary number (Ca), and Aspect ratio (Λ)--were calculated from 
the determined polymer solution physical properties and the operational 
parameters. The finished fibers array was sputter coated with a thin layer (t = 10 
nm) of gold-palladium alloy and imaging by SEM. The diameters of each fiber were 
measured and recorded at the middle point as well as 200 µm from the initiating 
and terminating side; the average of these values was used as the final fiber 
diameter. An ANOVA based on the gelatin characterization data was performed 
using Minitab software to find out the factors that significantly affect the response. 
Only those significant factors determined by the ANOVA were chosen to perform 
the linear regression analysis to generate the empirical model and contour plots. 
The empirical model included three dimensionless parameters (P - Ca - Λ), which 
related micro-fiber diameter to five independent variables (viscosity, surface 
tension, solvent evaporation rate, fiber length, and feed rate). Furthermore, the 
adequacy of the regression model also was checked through Minitab.  
 
3.3.4 Empirical Model Validation 
Because the empirical model was generated using only one biopolymer 
(gelatin), it is necessary to perform experiments with other biopolymers, 
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composites, and copolymers in order to validate the empirical model. A list of the 
biopolymers, solvents and their concentrations is shown in Table 3.4.  
Table 3. 4 Biopolymers used to validate the gelatin-based empirical model 
Biopolymer composition Solvent 
Concentration 
(wt.%) 
PLGA TFE 25% 
PLGA TFE 26% 
Gelatin/PLGA (70:30) TFE 17% 
Gelatin/PLGA (70:30) TFE 18% 
Gelatin/PLGA (50:50) TFE 18% 
Gelatin/PLGA (50:50) TFE 19% 
PLA Chloroform 28% 
PLA Chloroform 29% 
PLA-PEG (75:25) Chloroform 20% 
PLA-PEG (75:25) Chloroform 21% 
PLA-PEG (70:30) Chloroform 30% 




Based on the previous optimal results, the needle with an inner diameter of 
0.25 mm was chosen for the fiber fabrication. Micro-fibers array with lengths of 4, 
6, and 8 mm (each length for three fibers) were drawn at a feed rate of 200 mm/s 
for all biopolymer solutions. The biopolymer solution physical parameters and 
dimensionless parameters (P - Ca - Λ) were measured and calculated as previously 
described for the gelatin solution. The prediction data was then gathered by input 
of the dimensionless parameters into the empirical model. The experimental fiber 
diameters were also measured in three points by SEM as previously introduced in 
section 3.3.3.3. Then the experimental data was compared with the values 
predicted by the empirical model. 
 
3.3.5 Cells Seeding on Scaffold  
3.3.5.1 Cell Culture and Reagents 
Human Dermal Microvascular Endothelial Cells (HDMECs) (PromoCell 
GmbH, Heidelberg, Germany) were cultured in Endothelial Cell Growth Medium 
MV kit with growth supplement containing Fetal Bovine Serum (0.05 mL/mL), 
Epidermal Growth Factor (5 ng/mL), Basic Fibroblast Growth Factor (10 ng/mL), 
Vascular Endothelial Growth Factor 165 (0.5 ng/mL), Ascorbic Acid (1 µg/mL), and 
Hydrocortisone (0.2 µg/mL) (PromoCell GmbH, Heidelberg, Germany). The 
antibiotic-antimycotic containing 10,000 units/mL penicillin and 10,000 µg/mL 
streptomycin (GE Healthcare Bio-Sciences, Pittsburgh, PA) was also added to the 
medium kit with the growth supplement. 0.05% Trypsin/0.53 mM EDTA (Mediatech, 
Inc. Manassas, VA) was used to detach the cells when subculturing the cells. 
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One vial of cryopreserved HDMECs (~500,000 cells) was thawed for 3 
minutes in a water bath (37 ̊C). Then, the cell solution was pipetted into a T-25 
flask with 8 mL of growth medium and cultured for 2 days in the incubator (37 ̊C, 
5% CO2). Once it had reached 90% confluency, the cells were passaged into a T-
75 flask by using 1mL of 0.05% trypsin solution. The media was changed every 
two days. In 90% confluency, the cells were passaged again by 2 mL of 0.05% 
trypsin solution and 2 mL of media was added to obtain a total of 4 mL cells 
suspension solution. Cellometer was utilized at least twice to check the cell density, 
then the cells with known density could be seeded on the substrates of interest. All 
cells in this study were used between passages 3 and 8. 
3.3.5.2 Biodegradation Test 
Generally, it will take 6 months to 2 years to fully degrade PLA and 
PLGA[56]. Thus, it is very important to understand the degradation behavior of the 
biopolymers, composites, and copolymers. Using a bench top compression 
molding (Figure 3.30A), each biopolymer, composites, and copolymer were cast 
into several 15 mm diameter by 10 mm high cylinders (Figure 3.30B). Each 
sample cylinder was placed in a Petri dish and incubated with 15 mL of 1X 
phosphate-buffered saline (PBS) solution at body temperature (37°C) for up to 8 
weeks. PBS solution was changed every week to eliminate the acidic 
biodegradation products. At the end of each week, the sample cylinders were 
rinsed with DI water and vacuum dried for 30 minutes, then the mass lost were 




Figure 3. 30 Image of sample molding: A) Benchtop compression molding, B) 
example of molded PLA-PEG (75:25) sample cylinder  
3.3.5.3 Biopolymers Cellular Adhesion/Viability Test 
To evaluate if the chosen biopolymers, composites, and copolymers were 
suited for the HDMECs growth, a cellular adhesion test was performed. 400 µL of 
6% biopolymers solutions were deposited in the 24-well plate to form films. The 
films were then heated to 65 ̊C for 30 minutes and then left for 3 days in vacuum 
at room temperature to further remove residual solvent. Each film was sterilized by 
UV light exposure for 1 hour, coated with 200 µL of 5 µg/mL fibronectin aqueous 
solution, and incubated for 1 hour at 37 ̊C. After aspirated the fibronectin solution 
and washed with 1X PBS twice, HDMECs were seeded on each of the films at a 
density of 40,000 cells/cm2 (76,000 cells for each plate of a 24-well plate, bottom 
surface area = 1.9 cm2) and incubated for 24 hours at 37 ̊C. To count the quantity 
of the adhered cells on the film, each sample was fixed and stained with 4’,6-
diamidino-2-phenylindole  (DAPI). To check the cell viability, each sample was 
stained with a live/dead assay. The details of the staining procedure will be 
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introduced on section 3.3.5.6. Fluorescent images were taken by the fluorescent 
microscope and analyzed by  ImageJ software.  
3.3.5.4 Cell Seeding Conditions  
The basic idea of seeding cells on the scaffold is to submerge the scaffold 
in cell suspension and growth medium within a container, such as a 24-well plate 
or a chambered cover glass system. Three cell seeding conditions were studied to 
develop the optimal protocol for cell seeding onto the scaffold: (1) cells blocking, 
(2) adhesion promoters, and (3) cell seeding density. 
To reduce the attached cells on the bottom of the container,  bovine serum 
albumin (BSA) was used to block the bottom of the container. 0.2 mL of 0.01%, 
0.1%, and 1% of BSA (Sigma, St. Louis, MO) solution in 1X PBS was first added 
into the 24-well plate to cover the bottom of the well and incubated for 1 hour at 
37 ̊C. After aspirating the BSA solution, HDMECs were then seeded at a density 
of 40,000 cells/cm2 and incubated for 24 hours at 37 ̊C.  
Gelatin attachment factor and fibronectin are often used to coat culture 
surfaces to enhance the adhesion and growth of microvascular endothelial 
cells[201]. To evaluate the effectiveness of the cell adhesion promoters, cellular 
adhesion quantification experiments were conducted on both polymer films and 
fibers. Polymer films were fabricated in the 24-well plate through solvent casting 
from 400 µL of 6% PLA-PEG (75:25) copolymer solution in chloroform. Polymer 
fibers were fabricated on a custom cell culture fiber frame with a recessed platform 
via the direct-write system from 20% PLA-PEG (75:25) copolymer solution in 
chloroform. Each film and fiber was coated with 200 µL of 1x gelatin attachment 
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factor (AF, Cascade, Thermo Fisher Scientific, Waltham, MA), 5 µg/mL fibronectin 
(FN, Thermo Fisher Scientific, Waltham, MA) aqueous solution, and combined two 
promoters and then incubated for 1 hour at 37 ̊C. After aspirating the adhesion 
promoter solution, HDMECs were then seeded at a density of 40,000 cells/cm2 
and incubated for 24 hours at 37 ̊C. 
The micro-fiber scaffold will ultimately be submerged in the cell suspension 
during experimentation to capture the floating cells randomly. Thus, the seeding 
density may affect the final output of the cell adhesion. Three parallel PLA-PEG 
(75:25) micro-fibers with a distance of 2 mm were fabricated on the custom cell 
culture fiber frame with a recessed platform via the direct-write system. Each fiber 
was coated with 200 µL of 5 µg/mL fibronectin aqueous solution and incubated for 
1 hour at 37 ̊C. Then,  the fibronectin-coated fibers were transferred into a 0.1% 
BSA (incubated for 1 hour at 37 ̊C) pre-treated 24-wall plate. HDMECs were then 
seeded at a series seeding density: 40,000 cells/cm2, 60,000 cells/cm2. 80,000 
cells/cm2, and 100,000 cells/cm2. The cells were all incubated for 24 hours at 37 ̊C.  
For each of the experiments described, the number of attached cells was 
compared by the fluorescent images after the cells were fixed and stained with 
DAPI. Stained nuclei were counted by ImageJ software. Student t-tests were 
performed to identify the optimal seeding recipe. 
3.3.5.5 Cell Seeding on the Scaffold 
The fabricated scaffold on the custom frame was left under vacuum for 
overnight to make sure no residual solvent was left. Firstly, the custom frame was 
flipped (the recessed platform toward down) and put into a 24-well plate followed 
98 
 
by exposed under UV light in the laminar-flow hood for 1 hour. After the sterilization, 
the scaffold was covered with 0.1 mL of 5 µL/mL fibronectin solution and incubated 
at 37 ̊C for 1 hour. At the same time, another 24-well plate was covered with 0.1 
mL of 0.1% BSA solution and put into the incubator for 1 hour. Then, the fibronectin 
solution and BSA solution were aspirated along the inner wall of the well, and the 
fibronectin-coated scaffold was transferred carefully by a sterile tweezer to the 
BSA-coated well. This process needs to be completed extremely carefully because 
the scaffold is very easy to be broken by the vacuum or the surface tension induced 
by the meniscus of residual liquid. The procedure of 3.3.5.1 was followed to obtain 
enough HDMECs suspension with known cell density. For a 24-well plate (bottom 
surface area = 1.9 cm2), each wall needed to be seeded with 1.524 x 105 cells to 
reach a cell density of 80,000 cells/ cm2. The desired cell suspension volume was 
calculated based on the cell density. Then, the cell suspension was gently seeded 
on the scaffold, and the fresh media was added to the working volume (0.5 ml for 
24 wall plate). The 24-well plate was placed into the incubator while slowly rocking 
on a nutating mixer (Thermo Fisher Scientific, Figure 3.31) for 1 day to improve 





Figure 3. 31 Cells seeded on the scaffold with slow rocking on a nutating mixer in 
the incubator  
 
3.3.5.6 Immunofluorescent Staining 
Unless otherwise noted, all the samples observed under the fluorescent 
microscope and confocal microscope were first washed by 1X PBS for 1 minute, 
fixed by 3.7% formaldehyde for 10 minutes at room temperature, and then 
permeabilized in 0.1% Tween 20 for 5 minutes. 
3.3.5.6.1 DAPI and Rhodamine Phalloidin Staining 
The nucleus was stained by DAPI (300 µM, courtesy of Dr. Patricia Soucy) 
and the cytoskeleton was stained by rhodamine phalloidin (200 units/ml, Invitrogen, 
Thermo Fisher Scientific, Waltham, MA). The DAPI and rhodamine phalloidin was 
thawed, then diluted in 1X PBS (1:5) and 0.1% BSA solution (1:50), respectively. 
Each sample was incubated at 37 ̊C for 30 minutes in 0.1 mL of the diluted 
rhodamine phalloidin solution. The sample was covered properly to avoid solution 
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evaporation. After removing the rhodamine phalloidin solution and washing the 
sample twice with 1X PBS, 0.1 mL of diluted DAPI solution was added to cover the 
sample and standing for 3 minutes at room temperature. After washing three times, 
0.5 mL fresh 1X PBS was added to submerge the sample.I Imaging on the 
fluorescent or confocal microscope occurred immediately after. All the steps above 
were finished in the dark to protect the fluorescent dyes from light exposure. The 
best staining result was achieved by performing the fixation and staining on the 
same day. 
 
3.3.5.6.2 VE-Cadherin Staining 
VE-Cadherin staining was used to analyze the cell-cell junctions of cells 
adhered to the scaffold. Firstly, the primary antibody was prepared by diluting 
rabbit anti-VE cadherin (AB-33168, courtesy of Dr. Patricia Soucy) in 0.1% BSA 
(1:50). The secondary antibody was prepared by adding goat-anti-rabbit IgG Alexa 
Fluor 488 (A-11034, courtesy of Dr. Patricia Soucy) to 0.1% BSA with a dilution of 
1:40. Then, each sample was incubated at 37 ̊C for 30 minutes in 0.1 mL of the 
primary antibody. The sample was covered properly to avoid solution evaporation. 
Following 3 minutes of washing with 1X PBS, 0.1 mL of the secondary antibody 
was added to cover the sample and continued to incubate at 37 ̊C for 30 minutes. 
After washing another 3 minutes with 1X PBS, the samples were visualized using 
the confocal microscope with 0.5 mL fresh PBS as an anti-fade solution. All the 




3.3.5.6.3 Live/Dead Assay 
Live/dead assay (Invitrogen MP 03224, courtesy of Dr. Patricia Soucy) was 
used to study the cellular adhesion on different biopolymers as well as to check 
the viability of the cells on the scaffold in the ECM. The live cells are distinguished 
by the presence of ubiquitous intracellular esterase activity, determined by the 
enzymatic conversion the virtually nonfluorescent cell-permanent Calcein AM to 
the fluorescent calcein. EthD-1 enters cells with damaged membranes and 
undergoes a 40-fold enhancement of fluorescence upon binding to nucleic acids. 
EthD-1 is excluded by the intact plasma membrane of live cells. 
The sample for this experiment cannot be fixed. In addition, the staining 
solution should be made fresh each time in the laminar-flow hood and need to be 
protected from light exposure. By calculating the desired volume of staining 
solution, ethidium homodimer-1 (2 mM) was diluted to 4 µM, and Calcein AM (4 
mM) was diluted 2 µM in the same vial in serum-free media 200. After gently 
washing the cells with serum-free media 200 twice, 0.1 mL of the staining solution 
was added to cover the whole sample and incubated at 37 ̊C for 30 minutes. Then, 
the samples were ready to be viewed under the fluorescent microscope.  
 
3.3.5.7 Sample Preparation for SEM  
All the chemicals used in this experiment were purchased from Electron 
Microscopy Sciences (Hatfield, PA). The  experiment needed to be conducted in 
a fume hood for safety purposes. The cell-covered scaffold was gently washed 
with 1X PBS for 1 minute, then fixed in 2% paraformaldehyde, 2% glutaraldehyde, 
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0.1 M sodium cacodylate, and 3 mM sodium chloride (pH 7.4) at room temperature 
for 1 hour while slowly rocking. After washing with 1X PBS for 10 minutes, the 
sample was post-fixed in 0.8% potassium ferrocyanide-reduced 1% osmium 
tetroxide, 0.1 M sodium cacodylate, and 3 mM sodium chloride for 1 hour on ice in 
the dark. Following the DI water rinse (twice, 5 minutes each), the sample was 
then placed in 2% uranyl acetate-aqueous (0.22 µm filtered) for 1 hour at room 
temperature in the dark. Then, the sample was dehydrated through a graded series 
of ethanol with the following schedule: washed by 50%, 70%, and 90% ethanol 5 
minutes each, then washed by 100% ethanol three times for 5 minutes each. Upon 
completing the ethanol treatment, the sample was further dehydrated by washing 
with 0.5 mL hexamethyldisilazane (HMDS) for 5 minutes. After the HMDS was 
drained, the sample was placed in a desiccator overnight until it was completely 
dried. The sample received a 10 nm thick gold-palladium sputter coating before 
being observed under the SEM. 
 
3.3.6 Cells and Scaffold Embedded in ECM 
3.3.6.1 Collagen Gel Solution Preparation  
Type I collagen (rat tail, 8.34 mg/mL, Corning, NY) was used to work as 
ECM in this project. To prepare a 1 mg/mL collagen gel solution, the following 
components (courtesy of Dr. Patricia Soucy, Table 3.5) were added into a tube on 
ice and mixed for 1 minute with a pipette. NaOH was used to adjust the pH to 7.4 
and DI water was used to make the desired volume. The collagen gel solution was 
made freshly 5 minutes before encapsulating the cell-covered scaffold.  
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Example volume for  
400 µL solution 
NaHCO3 10 mg/ml 20 µL 
Collagen  8.34 mg/ml 48 µL 
PBS 10 X 40 µL 
HEPES 2 M 2 µL 
NaOH 1 M 15 µL 
DI water - 275 µL 
 
3.3.6.2 Gelation and Cell Culture 
To prevent the cells on the bottom of the well plate from migrating to the 
deposited collagen gel and interfering with imaging, the cell-covered scaffold 
needed to be transferred into a new container for ECM gelation. First, gently 
aspirated the medium along the inner wall of the 24-well plate to avoid damage to 
the scaffold induced by the liquid surface tension. Then, the cell-covered scaffold 
was washed by 1X PBS solution and carefully transferred into a new 24-well plate 
or chambered cover glass system by a sterile tweezer. Slowly, 0.1 mL freshly 
prepared collagen solution was added to fully cover the scaffold; samples were 
incubated for 35 minutes at 37 ̊C. After gelation finished, the desired amount of 
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media was added to a 24-well plate (0.5 mL) or a chambered cover glass system 
(1.5mL), and then continued to incubate for an additional 3 days. The media was 
changed every two days. 
3.3.6.3 Imaging Samples Preparation 
After the cells on the scaffold are cultured in the collagen gel for 3 days, 
fluorescent images were obtained by the fluorescent microscope and the confocal 
microscope to observe the cells growth in the ECM. The staining procedures were 
similar to the previously described in section 3.3.5.6. However, the fixation time, 
washing time, and staining time need to be doubled due to the slow diffusion in the 
collagen gel.  
To observe the ECM-cells-scaffold interaction and evaluate the scaffold 
degradation, SEM cross-sectional images of the scaffold embedded in collagen 
gel were captured. The procedure of section 3.3.5.7 was followed, butafter the 
HMDS treatment, the collagen gel film was still soft. If the gel film was left on the 
frame until it was completely dry, the film may tear or warp and would not be usable. 
To safely preserve the sample, the four sides of the gel film were gently cut and 
carefully transferred on to a PTFE surface. After the gel film completely dried, it 
was cut perpendicular to the scaffold axis with a sharp blade. The sample was 
attached onto a vertical SEM specimen stage and a 10 nm thick gold-palladium 






CHAPTER 4: RESULTS AND DISCUSSION 
In this chapter, the results associated with the specific aims outlined in the 
introduction will be examined. First, the fabrication results of the biopolymer micro-
fibers and branch structures will be presented. Next, the direct-write process will 
be characterized through the design of experiments (DOE), and an analysis of 
variance (ANOVA) will be conducted to determine the significant factors that are 
affecting the micro-fiber diameter. In the course of this investigation, an empirical 
model will be developed and validated to predict the micro-fibers diameter through 
the dimensional analysis. Then, the growth of the Human Dermal Microvascular 
Endothelial Cells (HDMECs) on the scaffold will be evaluated after culturing for 2 
days. Finally, the scaffold degradation and the ECM-cell-scaffold interactions will 
be evaluated once the cell-covered scaffold is embedded into the collagen gel.  
4.1 Fabrication of Biopolymer Micro-fibers and Branch Structures via 3-Axis 
Robotic Dispensing System 
It has been more than a decade since our group began to study the direct-
writing technique. Dr. Scott Berry first employed the Ultra-High Precision 
Micromilling Machine (UHPMMM) to generate micron-sized fibers from 
poly(methyl methacrylate) (PMMA) as well as a variety of biopolymers such as 
polycaprolactone (PCL), polylactic acid (PLA), and poly(lactic-co-glycolic acid) 
(PLGA)[181]. Furthermore, Dr. Hanwen Yuan utilized the 3-Axis robotic dispensing 
system to produce micro-/nano-fibers from PMMA and demonstrated the ability to 
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reach a higher yield compared to using the previous UHPMMM method[202]. In 
this project, we adopted the 3-Axis robotic dispensing system and successfully 
fabricated precisely-positioned, suspended micro-fibers and branched structures 
with microvascular-scale diameters from several natural, synthetic, and 
composites biopolymers.  
4.1.1 Gelatin, PLGA, and Composites 
Before the micro-fibers were produced, the optimal solvent was firstly 
identified for gelatin since there are a limited number of polar organic solvents with 
moderate volatility. Table 4.1 shows the solvent and concentration trials for gelatin. 
The acetic acid solution was excluded due to the poor fiber drawing ability. 2,2,2-
trifluoroethanol (TFE) was ultimately chosen based on the increased solubility 
characteristics of the gelatin and the fiber drawing ability. If the concentration is too 
high, the solution was observed to be very thick. The majority of the drawing 
attempts at the higher concentrations showed tensile failure and began to coil due 
to the lack of solvent during the drawing (Figure 4.1A). On the contrary, if the 
concentration is too low, the solution was observed to be very thin. Most of the 
drawing attempts at the low concentration experienced breakup failure, which may 








Table 4. 1 Solvent and concentration trials for gelatin 
Concentration Solvent Solution comments Fiber drawing ability 
22% 
TFE 
Two phases, form gel X 
20% Very thick gel X 
18% Dissolve well, very thick X 
17% Dissolve well, flow well ✓ 
16% Dissolve well, flow well ✓ 
15% Dissolve well, flow well ✓ 
14% Dissolve well, very thin X 
    
32% 
AA 
Cannot dissolve, sediment X 
30% Very thick gel X 
28% Dissolve well, very thick X 
27% Dissolve well, flow well X 
26% Dissolve well, flow well ✓ 





Figure 4. 1 SEM images of gelatin fibers drawn from the solutions which were: (A) 
very thick and (B) very thin. 
Once the solvent for gelatin was selected, the TFE solution concentrations 
for PLGA and gelatin/PLGA composites were also identified by trials, similar to the 
initial gelatin micro-fibers. These results are listed in Table 4.2.  
Table 4. 2 TFE solution concentration trials for PLGA and gelatin/PLGA 
composites 
Concentration concentration Solution Fiber drawing ability 
PLGA 24% Very thin X 
PLGA  25% Dissolve well ✓ 
PLGA  26% Dissolve well ✓ 
PLGA  27% Dissolve well X 
Gelatin/PLGA (70:30) 17% Dissolve well ✓ 
Gelatin/PLGA (70:30) 18% Dissolve well ✓ 
Gelatin/PLGA (70:30) 19% Dissolve well X 
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Gelatin/PLGA (50:50) 18% Dissolve well ✓ 
Gelatin/PLGA (50:50) 19% Dissolve well ✓ 
Gelatin/PLGA (50:50) 20% Two phases X 
 
Suspended gelatin, PLGA, and their composite micro-fibers with 
microvascular-scale diameters were successfully fabricated by the direct-write 
technique via the 3-axis robotic dispensing system. Figure 4.2A showed the 
gelatin droplet as the contact point and the end of the fiber, where the surface 
tension thinning began. It can also be observed in the PLGA fibers and 
gelatin/PLGA composite fibers. Figure 4.2B shows a single gelatin micro-fiber with 
a diameter of 14.46 µm (processing factors: solution concentration = 17%, needle 
ID = 0.25 mm, feed rate = 200 mm/s, and fiber length = 6 mm). Figure 4.2C shows 
one PLGA micro-fiber with a diameter of 6.88 µm (processing factors: solution 
concentration  = 27%, needle ID = 0.20 mm, feed rate = 300 mm/s, and fiber length 
= 8 mm). Figure 4.2D shows a single gelatin/PLGA composites fiber with a 
diameter 7.15 µm (processing factors: solution concentration = total 16% with 
gelatin/PLGA ratio of 70:30, needle ID = 0.25 mm, feed rate = 100 mm/s, and fiber 
length = 6 mm). According to the SEM images, these different biopolymer micro-
fibers all show a smooth cylindrical and bead-free morphology. The addition of 




Figure 4. 2 SEM images of the biopolymer micro-fibers fabricated with the 3-Axis 
robotic dispensing robotic system. A) End of gelatin fiber, B) gelatin micro-fiber 
with a diameter of 14.46 µm, C) PLGA micro-fiber with a diameter of 6.88 µm, and 
D) gelatin/PLGA (70:30) composite fiber with a diameter of 7.15 µm 
To further demonstrate the direct-write technique has the ability to precisely 
control the micro-fibers’ three-dimensional spatial position, freely suspended 
branched structures with different branching angles (60 ̊, 120 ,̊ and 150 ̊) were 
designed and fabricated on the acrylic frame. Figure 4.3A-C shows the fabricated 
gelatin branched structures with measured branching angles of 63 ̊, 116 ,̊ and 139 ̊, 
respectively (processing factors: solution concentration = 16%, Needle ID = 0.20 
mm, feed rate = 100 mm/s and fiber length = 8 mm). The relative errors for the 
actual angles of these branched structures are 5.0%, 3.3%, and 7.3%, respectively.  
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In section 2.1.1, we have learned that the capillary system consists of 
arterioles, capillaries, and venules, and those vessels have different diameter 
ranges. Thus, further developing a branched structure with varying diameters of 
micro-fiber could better mimic the real capillary system structure. One of the 
limitations of this 3-Axis robotic dispensing system is that the solution (i.e., 
concentration) and the needle cannot be changed during the fabrication process. 
However, the fiber diameter could still be controlled by varying the feed rate. 
Figure 4.3D shows a gelatin branched structure with a vertical supported fiber to 
mimic the arteriole (processing factors: solution concentration = 16%, Needle ID = 
0.20 mm, feed rate = 30 mm/s), whereas the branched fibers (Figure 4.3A-C) 
could work as the capillary. (remain other processing factors the same except for 
feed rate increase to 100 mm/s). Similarly, Figure 4.3E-F shows branched 
structures with different fiber diameters fabricated from gelatin/PLGA composites 
(70:30) and PLGA, respectively. Another factor that would affect the fiber diameter 
is the fiber length. Generally, the branched fibers are longer than the supported 
fiber (i.e., two times longer for the 60 ̊ branched structure) and have more 
touchdown point, which may cause extra stress and displace the supported fiber. 
Combined with different drawing speed, the different fiber diameters were 




Figure 4. 3 SEM images of the gelatin branched structures with different branching 
angles: A) 62.37 ̊, B) 115.96 ̊, and C) 139.42 ̊, and branched structures with 
different fiber diameters fabricated from: D) gelatin, E) gelatin/PLGA composites 
(70:30), and F) PLGA. 
 
The infrared spectra of the pristine gelatin, PLGA, and their composites are 
presented in Figure 4.4. The characteristic absorption bands for N-H stretching at 
3291.78 cm-1, amide I, C-O and C-N stretching at 1636.66 cm-1, and amide II, N-
H in-plane bending and C-N stretching at 1523.73 cm-1 could be found in the 
pristine gelatin and the different composites. The typical absorption bands for ester 
carbonyl stretching and vibration at 1749.91 cm-1 and C-O-C ether group stretching 
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at 1084.34 cm-1 were also found in pure PLGA and the composites. Increasing the 
amount of PLGA caused the intensity of C-O stretching and C-O-C group 
stretching peaks to decrease. No new peak or peak shifting was observed in the 
composites. This suggests that there is no new bond formed or strong chemical 
interaction occurred within the composites, which confirms the gelatin/PLGA 
composites are just simply a physical mixture. 
 
Figure 4. 4 FT-IR spectra of pristine gelatin, PLGA, and their composites  
 
4.1.2 PLA and PLA-PEG Copolymers 
Similarly, the optimal solvent selection for PLA and PLA-PEG copolymer 
was determined over several trials. Table 4.3 shows whether these polymer or 
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copolymers are soluble in the common organic solvents at a concentration of at 
least 20% by weight.  
Table 4. 3 Solvent trials for PLA and PLA-PEG copolymers 




PLA X X ✓ ✓ X 
PLA-PEG 
(90:10) 
X X ✓ ✓ X 
PLA-PEG 
(75:25) 
X X X ✓ X 
PLA-PEG 
(70:30) 
X X X ✓ X 
PLA-PEG 
(60:40) 
X X X ✓ X 
PLA-PEG 
(50:50) 
X X X ✓ X 
 
Chloroform was ultimately chosen based on the increased solubility of the 
polymers and moderate solvent volatility. Based on the preliminary experiments of 
copolymer degradation and fiber drawing ability, only PLA-PEG (75:25) and PLA-
PEG (70:30) were selected to draw the micro-fibers. PLA-PEG (75:25) solution 
was prepared by dissolving powder copolymer in chloroform of 20% and 21% by 
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weight; PLA-PEG (70:30) solution was prepared by dissolving powder copolymer 
in chloroform of 30% and 31% by weight. PLA solutions were prepared by 
dissolving bead-shaped PLA in chloroform of 28% and 29% by weight (Table 4.4). 
Table 4. 4 Selected concentration of PLA and PLA-PEG copolymer  
Polymers Solvent Concentration 
PLA Chloroform 28% 
PLA Chloroform 29% 
PLA-PEG (75:25) Chloroform 20% 
PLA-PEG (75:25) Chloroform 21% 
PLA-PEG (70:30) Chloroform 30% 
PLA-PEG (70:30) Chloroform 31% 
 
PLA and the selected PLA-PEG copolymers solutions were successfully 
processed into suspended micro-fibers with a microvascular-scale diameter by 
direct-write technique. Figure 4.5A presents the single suspended PLA micro-fiber 
with a diameter of 15.47 µm (processing factors: solution concentration = 28%, 
needle ID = 0.25 mm, feed rate = 100 mm/s, and fiber length = 6 mm); Figure 4.5B 
shows the PLA-PEG (75:25) copolymer micro-fiber with a diameter of 9.05 µm 
(processing factors: solution concentration = 21%, needle ID = 0.25 mm, feed rate 
= 100 mm/s, and fiber length = 8 mm); Figure 4.5C demonstrates the PLA-PEG 
(70:30) micro-fibers with a diameter of 6.52 µm (processing factors: solution 
concentration = 31%, needle ID = 0.25 mm, feed rate = 100 mm/s, and fiber length 
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= 10 mm). The SEM images indicate the produced micro-fibers have a smooth 
surface and no bead was observed for most of the surface.  
 
Figure 4. 5 SEM images of representative single suspended micro-fibers fabricated 
by the 3-Axis robotic dispensing system. A) PLA fiber with the diameter of 15.47 
µm, B) PLA-PEG (75:25) fiber with the diameter of 9.05 µm, and C) PLA-PEG 
(70:30) fiber with the diameter of 6.52 µm. 
PLA and PLA-PEG copolymer were also used to produce suspended 
branched structures. Figure 4.6A-B shows PLA and PLA-PEG (75:25) copolymer 
branched structures both with a vertical supported fiber and the branched fibers, 
respectively (processing factors for PLA: solution concentration = 28%, needle ID 
= 0.25 mm, feed rate = 100 mm/s; processing factors for PLA-PEG (75:25 
copolymer): solution concentration = 21%, needle ID = 0.25 mm, feed rate = 100 





Figure 4. 6 SEM images of the representative branched structures fabricated by 
the direct-write technique from different biopolymers. A) PLA; B) PLA-PEG (75:25) 
copolymer. Inserted images showed the enlarged intersection area. 
 
Besides producing single intersection branched structures, the 3-Axis 
robotic dispensing system is able to generate several complex structures by 
precisely controlling the dispensing tip to move among the predefined spatial spots, 
including the initiating, terminating, and intersection points. Figure 4.7A shows a 
web structure with triple intersections and all the branching angles designed to 90 .̊ 
The actual angles for those three branched fibers are 88.9 ̊, 84.7 ,̊ and 100.3 ̊, with 
a relative error of 0.9%, 4.4%, and 8.6%, respectively. The relative error increased 
with the drawing order; the probable reason is that the tension induced from the 
previous fiber may move the supported fiber and lead the displacement of the 
following fiber. Figure 4.7B demonstrates a dual-intersections branched structure 
with different branching angles (designed to 60 ̊ and 120 ̊). The measured angles 
are 59.2 ̊and 113.9 ̊, with a relative error of 1.3% and 5.1%, respectively. Figure 
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4.7C-D shows the parallel fiber arrays and overlapping fibers with orthotropic 
structure, in which all fibers in those structures are within the microvascular-scale 
diameters. Although those two structures are not similar to the real capillary system, 
they still have the potential application value such as to be used to study the 
angiogenesis behaviors of the endothelial cells between neighboring vessels. 
 
Figure 4. 7 SEM images of complex suspend structures fabricated from PLA-PEG 
(75:25) copolymer by direct-write technique. A) A branched structure with triple 
intersections; B) a dual-intersections branched structure; C) parallel fibers array; 




The pristine PLA, PEG, and PLA-PEG copolymers were characterized by 
using FT-IR and 1H-NMR. The infrared spectrum is presented in Figure 4.8. A 
strong absorption peak at 1746.77 cm-1 was observed in the PLA, which confirmed 
the presence of the ester stretching. Meanwhile, the FT-IR spectrum of PEG and 
the copolymers showed characteristic peaks at 2887.45 cm-1 and 3458.25 cm-1, 
which correspond to C-H stretching and terminal hydroxyl group O-H stretching, 
respectively. For the series of copolymers, the ester stretching peaks could be 
seen at 1757.88 - 1759.32 cm-1. The peaks shifting indicate the formation of the 
copolymers. The C-H stretching and O-H stretching peaks were also observed in 
those copolymers between 2885.36 - 2888.12 cm-1 and 3456.11 – 3459.43 cm-1, 
respectively. The intensity reduction of these two peaks also suggests there may 
be a new bond formed from the weak chemical interaction between the PLA and 




Figure 4. 8 FT-IR spectra of pristine PLA, PEG, and PLA-PEG copolymers 
 
To further confirm the copolymer formation, the 1H-NMR spectra of pristine 
PLA, PEG, and PLA-PEG copolymers are also shown in Figure 4.9 (stacked 
images with 15  ̊tilt). For the PLA micro-fibers, the chemical shift at 5.15 ppm and 
1.52 ppm was observed, which corresponded to CH- and CH3- bond, respectively. 
The calculated integration ratio for these two peaks is 1:3.1, which confirms the 
two types of hydrogen protons found in the chemical structure of PLA. For the PEG 
micro-fibers, we found a single peak with a chemical shift at 3.63 ppm, which 
indicates the CH2- bond. The series spectra of the copolymers show new peaks at 
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4.29 ppm. We speculate those peaks corresponded to the CH2-O hydrogen 
protons from the newly formed ester bond (highlighted with the red circle in Figure 
4.9). The new ester may be formed between the break of C(O)-O bond from PLA 
and CH2-OCH2 bond from PEG. In general, the intensity of the new peaks shows 
a reduction trend with the decreasing concentration of PEG, which suggests 
incomplete copolymerization due to the lack of the CH2-OCH2 bond from PEG. We 
also performed a polymer molecule NMR simulation by ChemNMR 1H Estimation 
(Figure 4.10). For the given copolymer molecule with an ester group, a chemical 
shift appears at 4.27 ppm; this trend is observed in our actual 1H-NMR spectra of 










Figure 4. 10 ChemNMR 1H Estimation of the formed copolymer  
 
4.2 Characterization and Modeling of the Direct-write Process 
We have demonstrated the ability to process a variety of biopolymers into 
micro-fibers and branched structures with microvascular-scale diameters by the 
direct-write technique using the 3-Axis robotic dispensing system. In order to better 
understand the micro-fiber formation mechanism behind the thinning dynamics of 
biopolymer solutions, the direct-write process needed to be characterized so that 
we can find out what process factors affected the micro-fiber yield and diameter. 
An empirical model generated from the characterization process could reveal the 
correlation among the fiber diameter to polymer solution properties and system 
process parameters. The empirical model also may offer future users the ability to 
employ the 3-Axis robotic dispensing system to direct-write micro-fibers without 
trial-and-error work. The empirical model was validated by comparing the 
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prediction and experimental value of the diameters of the micro-fibers of various 
biopolymers other than gelatin. 
 
4.2.1 Characterization of the Direct-write Process 
4.2.1.1 Process Factors Reduction 
There are eleven controllable variables involved in the direct-write process 
(Figure 4.11). The factors highlighted in orange are the solution physical 
properties, whereas those highlighted in blue are the process factors defined by 
the 3-Axis robotic dispensing system. Investigating all of these variables at once 
would result in a model with a large amount of uncertainty; thus, some variables 
must be set as constants. Based on the direct-write experiences from our group, 
valve pressure (15 psi) and dispensing time (0.2 seconds) were set as constant 
for the maximum performance of this system.  
 




Before the fiber was drawn, the polymer drop’s size (D0) is critical because 
it could be used to define the needle/substrate gap (Figure 3.28) and calculate the 
aspect ratio (𝛬) for dimensional analysis (Equation 3-11). Figure 4.12 and Table 
4.5 present the D0 measurements of the 16% gelatin solution with different needles 
(0.25 mm, 0.20 mm, 0.15 mm, and 0.10 mm) and valve open time (0.02 s, 0.05 s, 
0.1 s, and 0.5 s) under constant valve pressure (15 psi). Valve open time (0.1 
second) was selected for the future drawing to reduce the system complexity and 
further define the needle/substrate gap.  
 
 
Figure 4. 12 Optical images of the gelatin solution drops with different needles and 





Needle ID (mm) 
Table 4. 5 Gelatin polymer drop diameter measurements 
 
Polymer Drop Diameter (µm) 
0.02 s 0.05 s 0.1 s 0.5 s 
0.25 (red) 460.9 ± 15.1 482.7 ± 4.3 548.1 ± 7.9 622.0 ± 11.3 
0.20 (clear) 433.0 ± 3.8 454.2 ± 10.6 484.4 ± 13.9 539.6 ± 9.8 
0.10 (lavender) 391.9 ± 7.1 417.8 ± 13.5 435. 5 ± 7.2 444.4 ± 18.8 
0.10 (yellow) 365.8 ± 12.8 404.0 ± 15.3 371.8 ± 12.3 394.1 ± 12.9 
 
In Figure 4.13, it is demonstrated how the needle/substrate gap could affect 
the contact between the polymer droplet and the substrate. When the gap was too 
small (second images for each needle), it was found that the polymer droplet would 
cause fouling outside of the needle. The fouling causes difficulty in producing a 
continuous direct-write series of fibers. If the gap was too big (fourth images for 
each needle), most of the fiber failed because the minimal contact reduces the 
adhesion between the polymer droplet and the substrate. The ideal 
needle/substrate gap was shown in the third images for each needle: 400 µm for 
the red needle, 300 µm for the clear needle, 250 µm for the lavender needle, and 
200 µm for the yellow needle.  





Figure 4. 13 Optical images of direct-write polymer droplet with differing 
needle/substrate distances across different needle inner diameters. A) 0.25 mm, 
B) 0.20 mm, C) 0.15 mm, and D) 0.10 mm  
 
4.2.1.2 Design of Experiments  
After reducing the number of variables, the significance of the physical 
properties of the solution and machine process factors were investigated by 
utilizing an unbalanced four factors multi-level full factorial design of experiment. 
Arrays of gelatin micro-fibers were fabricated on the substrate using the 3-Axis 
robotic dispensing system from different combinations. Figure 4.14 presents an 
example of how to measure the fiber diameter through the SEM. The diameters of 
each fiber were measured and recorded at the middle point as well as 200 µm from 
the initiating and terminating side, and the average value was used as the final 
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fiber diameter. Examples of gelatin fibers in different diameters range are shown 
in Figure 4.15. 
 
Figure 4. 14 Example of measuring the diameter of the micro-fiber from the fibers 
array by the SEM. 
  
Figure 4. 15 SEM images of gelatin fibers with different fiber diameters from the 





Statistical analysis of the experimental data has been done using an 
ANOVA. ANOVA enables us to gain insight into the direct-write process by 
distinguishing which factors have significant effects on the mean fiber diameter. 
The ANOVA table for fiber diameters is shown in Table 4.6. The “main effects” 
plots of the mean fiber diameter as a function of four different factors are presented 
in Figure 4.16. We can see that all four selected factors are significant for fiber 
diameters (p = 0.000). Generally, the mean fiber diameters increased with 
increasing solution concentration and the needle’s inner diameters and decreasing 
feed rate and fiber length. The solution concentration could further affect three 
measurable physical properties: viscosity, surface tension, and mass transfer 
coefficient; thus, the more accurate fiber diameter correlation will be illustrated in 
the empirical model section later. 






Figure 4. 16 The “main effects” plots of the mean of fiber diameter as a function of 
concentration (%), needle ID (mm), feed rate (mm/s), and fiber length (mm) 
 
The effects of these four factors on the fiber yield are presented in Figure 
4.17. Figure 4.17A suggests the 16% gelatin solution has a higher yield (~79%) 
compared to 15% and 17%. Figure 4.17B shows that the fiber yield increased with 
the increasing needle’s inner diameter due to the enlarged initial polymer droplet 
diameter (D0). The feed rate also significantly affects the fiber yield (Figure 4.17C). 
Fiber drawn at 200 mm/s shows the highest yield (~77%), while feed rates that are 
too slow or too fast will both decrease the fiber yield. Figure 4.17D illustrates the 
relationship between the fiber yield and the fiber length. This general trend 
suggests that at a shorter length (<8mm), the fiber yield remained at a high level 






Figure 4. 17 Yield of direct-writing gelatin fibers versus several factors: A) 
concentration (%), B) needle inner diameter (mm), C) feed rate (mm/s), and D) 
fiber length (mm). 
The DOE indicates that several requirements need to be met to fabricate 
micro-fibers successfully with the direct-write method. First, rheological properties 
of the solution should be appropriately examined. During the drawing process, the 
appropriate choice in solution concentration and needle size ensures that the 
solution has sufficient surface tension to achieve the necking effect, enough 
viscosity to resist capillary breakup, and proper volatility to promote solidification 
of the fiber. Second, the drawing process factors also should be finely tuned. The 
proper workable feed rate and fiber length ensures either the drawing velocity is 
not too fast to avoid uncompleted surface tension-driven thinning and the fiber is 
not too long to cause excessive thinning, resulting in probable breakup. 
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4.2.2 Generation of the Empirical Model 
4.2.2.1 Characterization of Gelatin Solution 
The physical properties of the gelatin solutions are summarized in Table 
4.7. The one-way ANOVA results illustrate both the viscosity and surface tension 
of the gelatin solution significantly increase with increasing gelation concentration 
(p < 0.001).The mass transfer coefficient is independent of concentration due to 
the same solvent and solution/air interface area.  








coef., χ (m/s) 
15  0.93 ± 0.08 27.52 ± 0.46 2.36E-07 
16  1.12 ± 0.11 30.50 ± 1.22 2.36E-07 
17  1.70 ± 0.04 39.18 ± 0.80 2.36E-07 
 
The gelatin on dry status is a long chain of polymer molecules, which coil 
and associate with each other through specific, cooperative, non-covalent junction 
zones. Strictly speaking, the solution should be a non-Newtonian fluid. However, 
Stainsby et al. firstly pointed out that a concentrated gelation solution behaved like 
a Newtonian fluid at a temperature above the gel point[203]. We could estimate 
the apparent shear rate at the needle wall by approximating the solution as 
Newtonian fluids and adopting the equation as below: 
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𝛾′ =  
4𝑄
𝜋𝑅3
                                           (4-1) 
Where 𝛾’ is the apparent shear rate at the needle wall, Q is the volumetric 
flow rate, and R is the inner radius of the needle. Figure 4.18 shows the 
relationship between shear rate and viscosity for gelatin solutions with different 
concentrations. The viscosity remains constant with the various shear rate from 
~0.1 to ~200 s-1. During the direct write process, the typical flow rate was ~0.68 
mL h-1 to ~3.70 mL h-1 and the calculated shear rates were approximately ~15-83 
s-1 (the region between the red dotted lines). Based on the results, it was confirmed 
that the gelatin solutions conform to the assumption of Newtonian-like fluid during 






Figure 4. 18 The viscosity of gelatin solutions under different shear rates 
 
4.2.2.2 Dimensional Analysis for Empirical Model Generation  
The dimensional analysis is employed to obtain a certain set of information 
about a given physical issue. Through the dimensional analysis, we can reduce 
the multifaceted nature of a physical problem by removing variables that have 
limited influence on the given issue. In section 3.3.3.1, we introduced the 
Buckingham Pi theorem and showed how to group six parameters into three 
dimensionless parameters by selecting MLt (mass, length, and time) dimensions. 
The factors, symbols, and dimensions of the process factors used for the 
development of the empirical model are shown in Table 4.8. The dimensionless 
parameters P and Ca (Table 4.9) were calculated from the polymer solution 
physical properties in Table 4.7 by using Equations 3-7 and 3-10. The Aspect 
ratio (𝛬) was calculated from the polymer droplet diameter in Table 4.5 by using 
Equation 3-11. The values range from 7.30-72.99 based on the different fiber 








Table 4. 8 Factors, symbols, and dimensions of the response, process factors, and 
the dimensionless parameters 
 Factors Symbol Dimensions 
Response  Fiber diameters D∞ [ L ] 
Process 
Factors 
Viscosity η [ ML-1T-1] 
Surface tension σ [ MT-2 ] 
Mass transfer coefficient χ [ LT-1 ] 
Feed rate U [ LT-1 ] 
Fiber length L [ L ] 
Dimensionless 
Parameters 
Processability parameter P - 
Capillary Number Ca - 
Aspect ratio Λ - 
 










15 7.98E-06 3.38 6.76 10.14 
16 8.67E-06 3.67 7.34 11.02 




A regression analysis was employed on the calculated dimensionless 
parameters using Minitab to generate the empirical model. The Box-Cox 
transformation was performed on the regression model to ensure accuracy was 
maintained. A second order polynomial regression was selected based on the 
highest adjusted R2 (86.73%) to avoid overfitting. The formed regression equation 
in terms of three dimensionless parameters is shown in Equation 4-2: 
(𝐷𝑡)
0.085 = 878006𝑃 − 431617577200𝑃2 − 0.00561𝐶𝑎 +
                            0.000186𝐶𝑎
2 − 0.003251𝛬 + 0.00012𝛬2 − 3.094      (4-2) 
The ANOVA for the transformed response is given in Table 4.10. The “main 
effects” plots of the mean of fiber diameter as a function of the three dimensionless 
parameters are presented in Figure 4.19. Also, three surface graphs are also 
plotted to visualize the effects of the dimensionless parameters. Figure 4.20 
demonstrates the trend of fiber diameters in terms of variations in the 
dimensionless parameters. The surface graphs were produced by plotting two 
variables on the X and Y axis and the other held at their mean level. The results 
indicate that both the Processability parameter and Aspect ratio are significant 
factors (p = 0.000). The fiber diameter increased with the increasing Processability 
parameters, suggesting the combination of low surface tension, high viscosity, and 
solvent evaporation rate could cause the polymer to resist the thinning process to 
form a larger fiber. Also, it was discovered that the fiber diameter decreased with 
the increasing Aspect ratio; the small polymer droplet and long fiber length will 
prompt the thinning process, forming a smaller fiber. The Capillary number also 
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affected the fiber formation with a significance of p = 0.0012. The Capillary number 
accounts for the non-instantaneous nature of the direct-write method from the 
robotic dispensing system. A higher Ca indicates that drawing is too fast to allow 
the surface-tension-driven thinning to complete. In contrast, lower Ca illustrates 
that excessive thinning may occur during the drawing and results in a probable 
breakup.  
 





Figure 4. 19 The “main effects” plots of the mean of fiber diameter as a function of 


































Capillary number Aspect ratio





Figure 4. 20 Surface plots representing the fiber diameter as a function of A) 
Aspect ratio and Capillary number; B) Processability parameters and Capillary 
number, and C) Aspect ratio and Processability parameters. 
 
The adequacy of the linear regression analysis was checked by residual 
plots in Figure 4.21. First, the normal probability plot and histogram confirmed that 
the residuals from the empirical model are approximately randomly distributed. The 
residuals against fitted values and observation order showed that each residual 




Figure 4. 21 Plots of the normal probability and histogram of residuals, as well as 
residuals against the fitted value and observation order 
 
4.2.3 Validation of the Empirical Equation 
The empirical model was generated from the DOE of gelatin solutions in 
TFE and revealed the correlation between the micro-fiber diameter, the physical 
properties of the polymer solution, and the direct-write process factors. Since the 
polymers are a series of long-chain molecules and their solution could be 
expressed with similar fundamental physical properties, we assume the empirical 
model could be adopted to predict the diameters of direct-write micro-fibers from 
other polymer/solvent systems. To test this assumption, we utilized the 3-Axis 
robotic dispensing system to process various biopolymers into a micro-fiber array. 
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The experimental data of the micro-fiber diameters was obtained and compared 
with the value predicted by the empirical model.  
Biopolymers in Table 3.4 were fabricated into a micro-fiber array with fiber 
lengths of 4, 6, and 8 mm (three fibers for each length). The yield of those micro-
fibers is shown in Figure 4.22. The yield for most of the produced biopolymer 
surpassed 65%. However, the yield of 18 wt.% and 19wt. % gelatin/PLGA (50:50) 
solution were 32% and 22%, respectively. The same situation was observed in 
PLA-PEG (70:30) copolymer fiber; the yield for 30 wt.% and 31 wt.% solution were 
only 11% and 22%, respectively. We speculate that the combined low viscosity 
and high surface tension caused the capillary breakup. In addition, the solvent 
used in the PLA-PEG copolymer is chloroform, which has a lower boiling point than 
TFE. The solvent would gradually evaporate in the polymer barrel because it is not 
air-tight. The relatively high volatility may increase the actual concentration of the 





Figure 4. 22 The micro-fiber yield of various direct-written biopolymers  
The physical properties of various biopolymer solutions were measured 
following the previously described method in Chapter 3. The results are presented 
in Table 4.11. Next, the dimensionless parameters were calculated based on the 
obtained physical properties and the process factors (Table 4.12). Then, the 
calculated dimensionless parameters were used in conjunction with the empirical 
model (Equation 4.2) to calculate the predicted micro-fiber diameters. Although 
all the biopolymers solutions could be processed to micro-fibers through the 3-Axis 
robotic dispensing system, not all the experimental data could be substituted into 
the model to get the prediction value due to the biopolymers’ Processability 
parameters are excess of exceeding the empirical model range. The distribution 
of the Processability parameters of the various biopolymers’ solution is shown in 
Figure 4.23. The space between the two orange lines in Figure 4.23 indicates the 
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empirical model boundary (~7-13 x10-6), while the Processability parameters of the 
solutions of 18 % Gelatin/PLGA (70:30) composites, 28% PLA, 29% PLA, 32% 
PLA-PEG (70:30), and 33% PLA-PEG (70:30) copolymers are outside of the 
boundary. Thus, the predictions for those biopolymers are excluded from the 
empirical model validation. 











25% PLGA 2.12 ± 0.14 45.55 ± 1.59 2.40E-07 
26% PLGA 2.84 ± 0.29 65.33 ± 3.23 2.40E-07 
17% Gelatin/PLGA(70:30) 1.02 ± 0.06 35.17 ± 2.11 2.54E-07 
18% Gelatin/PLGA(70:30) 1.98 ± 0.11 39.98 ± 0.92 2.49E-07 
18% Gelatin/PLGA(50:50) 0.88 ± 0.02 56.03 ± 2.43 2.31E-07 
19% Gelatin/PLGA(50:50) 1.38 ± 0.16 36.03 ± 2.43 2.26E-07 
28% PLA 2.57 ± 0.08 51.23 ± 2.66 4.89E-07 
29% PLA 3.01 ± 0.26 49.48 ± 1.77 4.83E-07 
20% PLA/PEG(75:25) 0.98 ± 0.04 29.88 ± 0.82 3.14E-07 
21% PLA/PEG(75:25) 1.23 ±0.15 30.54 ± 1.24 3.14E-07 
30% PLA/PEG(70:30) 0.49 ± 0.20 58.87 ± 2.88 3.14E-07 















25% PLGA 1.12E-05 9.31 7.63 11.45 15.27 
26% PLGA 1.04E-05 8.69 8.21 12.32 16.43 
17% Gelatin/PLGA(70:30) 7.37E-06 5.80 7.35 11.03 14.71 
18% Gelatin/PLGA(70:30) 1.23E-05 9.90 7.77 11.65 15.53 
18% Gelatin/PLGA(50:50) 3.63E-06 3.14 6.81 10.22 13.63 
19% Gelatin/PLGA(50:50) 8.66E-06 7.66 7.72 11.58 15.44 
28% PLA 2.45E-05 10.03 9.26 13.89 18.52 
29% PLA 2.94E-05 12.17 12.38 18.58 24.77 
20% PLA/PEG(75:25) 1.03E-05 6.56 7.35 11.03 14.71 
21% PLA/PEG(75:25) 1.26E-05 8.06 7.97 11.95 15.94 
30% PLA/PEG(70:30) 2.61E-06 1.66 6.69 10.03 13.38 




Figure 4. 23 The distribution of the Processability parameters of various 
biopolymers  
 
The micro-fiber diameters were measured through the SEM as we 
introduced in section 4.2.1.2. The predicted values were obtained from Minitab by 
substituting all the calculated dimensionless parameters into the generated model. 
The experimental and predicted diameters of micro-fibers with lengths of 4, 6, and 
8 mm for the selected biopolymers are presented in Figure 4.24. Generally, the 
micro-fiber diameter decreased with increasing fiber length. Also, there is a 
noticeable trend of the micro-fiber diameter increasing with the increasing 
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biopolymer solution concentration. The result is consistent with the previously 
made conclusion that we made earlier in the gelatin fiber characterization process.  
 
Figure 4. 24 Comparison of the predicted and the experimental diameters of the 
direct-write micro-fibers for various biopolymers, composites, and copolymers 
(micro-fiber length of 4, 6, and 8 mm) 
Finally, we used three measures to evaluate the performance of the 
prediction of the empirical model. The measures are presented in Table 4.13: 
mean absolute deviation (MAD), mean squared deviation (MSD), and the mean 
absolute percentage error (MAPE). The mean absolute error and mean absolute 





Table 4. 13 Measurement of the prediction error  
Length MAD (µm) MSD (µm2) MAPE (%) 
4 mm 6.65 75.70 46.61 
6 mm 5.51 50.34 47.98 
8 mm 5.15 48.80 59.25 
Average 5.77 58.28 51.28 
 
4.3 Direct-write Microvascular Scaffold for Endothelial Cells Morphogenesis  
4.3.1 Biopolymer Selection for Scaffold  
4.3.1.1 Biodegradation Test  
From our preliminary cell culture experiments, we found that the gelatin and 
gelatin/PLGA composites were still water soluble. If made of these polymers, most 
of the fabricated scaffold will be totally dissolved in the cell medium at 37 ̊C within 
less than 2 hours. Thus, crosslinking of the gelatin and gelatin/PLGA composites 
was performed to improve the water-resistant ability of the micro-fibers. After 
comparing common crosslink methods such as oxygen species and 
glyceraldehyde solutions, the vapor-phase glutaraldehyde method was selected 
because this is the only method that will not significantly increase the micro-fibers 
diameters[204]. Therefore, in this experiment, all the gelatin and gelatin/PLGA 
composites samples were treated with glutaraldehyde vapor (50%) for 3 hours in 
a sealed desiccator at room temperature. PLA-PEG (60:40) and PLA-PEG (50:50) 
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were not evaluated in this test because they cannot be processed into micro-fibers 
through the 3-Axis robotic dispensing system. 
The samples of the studied biopolymers underwent the biodegradation test 
in the PBS solution at 37 ̊C simulating in vivo conditions. Figure 4.25 shows the 
biodegradation profiles for various biopolymers. The pure PLA showed the lowest 
degradation rate, more than 85% of the weight remained after 8 weeks. However, 
the PLA-PEG copolymers showed a much higher degradation rate compared to 
PLA. The PLA-PEG (90:10) and PLA-PEG (75:25) copolymers had 76% and 47% 
of the sample weight remaining, respectively. It should be noted that the PLA-PEG 
(70:30) broken into small pieces in 4-5 weeks. The reason the copolymer had a 
higher degradation rate is that the ester bonds formed in the copolymer are broken 
much easier due to a hydrolytic reaction. It can also be observed that the 
crosslinked gelatin  withstood the aqueous environment more rigorously than 
traditional gelatin, with 36% weight loss measured at the end of the experiment. 
The PLGA degrades slowly, showing a 16% weight loss. The gelatin/PLGA 
composites exhibited a moderate degradation rate that was between the rate of 
the PLGA and gelatin samples. The two composites were observed to break into 
small pieces after 6 weeks. In summary, although the improvement of the 
degradation was not ideal , both the composites and copolymers could increase 
the degradation rate compared to the pure PLA and PLGA. According to this 
experiment, the crosslinked gelatin, PLA-PEG (75-25), and PLA-PEG(70:30) are 




Figure 4. 25 The degradation profile for various biopolymers, composites, and 
copolymers. Gelatin and gelatin/PLGA were all crosslinked by glutaraldehyde 
vapor. Error bars were not shown for clear visualization. X represents that the 
polymer cubes broke into small pieces.  
4.3.1.2 Biopolymers Cellular Adhesion and Viability Test 
After evaluating the biopolymer’s degradation ability, it is important to 
examine if the biopolymers are suited for the HDMECs growth. The cellular 
adhesion potential of the biopolymers and the viability test results are presented in 
Figure 4.26. The green and red color represent the live cells and dead cells, 
respectively. It could be seen that only a few viable cells were detected in the 
crosslinked gelatin and gelatin/PLGA composites. One possible reason for this is 
the toxicity of the crosslinking agent – glutaraldehyde. It has been reported that the 
potential source of cytotoxicity of the crosslinker  may be residue of unreacted 
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crosslinking agent that leaches into the cell media. We also initially speculated that 
the cytotoxicity may be a result of the solvent TFE. However, this speculation could 
be ruled out because the PLGA dissolved in TFE (not treated by the glutaraldehyde 
vapor) possesses a much higher viable cell count. The PLA and PLA-PEG 
copolymers generally showed high cell viability. Although the PLA-PEG 
copolymers with improved hydrophilicity were expected to grow more cells than 
PLA, we observed that the attached cell count for the copolymers was less than 
the PLA; the attached cell count decreased with increasing the content of PEG 
segments in the copolymer. This trend has also been reported before: PEG 
segments could reduce the binding of proteins and cell adhesion on the material 
surface[205]. Thus, PLGA, PLA, and PLA-PEG copolymers are all potential 




Figure 4. 26 Cellular adhesion and viability profiles for various biopolymers  
Considering the multiple factors involved in the direct-write yield, the 
biodegradation rate, and the HDMECs adhesion ability and viability 
comprehensively, the PLA-PEG (75:25) copolymer was selected for the  
microvascular scaffold study.  
 
4.3.2 Cell Seeding Conditions 
4.3.2.1 BSA Coating Experiment 
A critical goal of this project is to  ensure the HDMECs could adhere to the 
suspended scaffold and proliferate on it. Besides the gentle rocking of the well 
plate to increase the possibility that the suspending cells could contact the scaffold, 
we could also block the bottom of the well plate. The BSA coating has proved to 
be one of the efficient ways to avoid cell adhesion on the bottom on the well plate 
for HUVECs[201]. Figure 4.27 shows the blocking effects of different 
concentrations of the BSA coating for HDMEC cell adhesion. It can be concluded 
that the BSA coating significantly reduced the cells number that attached on the 
bottom of the well plate (p < 0.002). The result also indicated that the concentration 
of BSA did not influence the blocking of the HDMECs, possible because that even 
the BSA solution with concentration as low as 0.01% was enough to form a uniform 





Figure 4. 27 The comparison of cell density on the bottom of the well plate after 
applying a BSA coating at different concentrations 
 
4.3.2.2 Adhesion Promoters Comparison  
In order to further enhance the adhesion of the HDMECs on the surface of 
the scaffold, adhesion promoters such as gelatin-based attachment factor (AF) and 
fibronectin (FN) were applied on both PLA-PEG (75:25) copolymer films and micro-
fibers. Figure 4.28 displays the fluorescent images (nuclei with DAPI) of the 
HDMECs adhered on the copolymer films and micro-fibers with different adhesion 
promoters. The statistical result is presented in Figure 4.29. With the surface 
modifications of AF, FN, and their combination, the attached cells number on the 
films had a higher cell count than the non-treatment control (p = 0.101, p = 0.030, 
and p = 0.044, respectively). It can be observed that the difference in successful 




Figure 4. 28 Fluorescent images of the HDMECs adhered on copolymer films and 
micro-fibers with different adhesion promoters 
 
 
Figure 4. 29 The quantity of attached cells on the copolymer films and micro-fibers 





4.3.2.3 Cell Seeding Density Experiment  
The preliminary culture experiments indicated that the initial HDMECs 
seeding density of approximately 40,000 cells/cm2 was insufficient due to most of 
the scaffold only having cells scattered on its surface. According to our seeding 
strategy, the suspended cells would randomly adhere and grow on the scaffold 
under the influence of gravity and external stimulation, such as rocking. We 
anticipate the increasing cell seeding density could improve the output. Figure 
4.30A-D shows the fluorescent images of the HDMECs adhered on the copolymer 
micro-fibers with a series seeding density: 40,000 cells/cm2, 60,000 cells/cm2. 
80,000 cells/cm2, and 100,000 cells/cm2. Figure 4.30E illustrates the statistical 
results of this experiment. It can be seen that when increasing seeding density, the 
number of adhered cells on the length of the micro-fiber increased significantly (p 
= 0.013, p = 0.001 and p = 0.000, respectively). Although a higher initial seeding 
density could obtain a higher cell count on the micro-fiber, the result suggests that 
the difference between 80,000 and 100,000 cells/cm2 is not significant (p = 0.800). 
Considering the cost and time involved in culturing cells, we chose the seeding 




Figure 4. 30 Fluorescent images of the HDMECs adhered on the micro-fiber with 
seeding density of A) 40000 cells/cm2, B) 60,000 cells/cm2, C) 80,000 cells/cm2, 
and D) 100,000 cells/cm2. E) Differences in the quantity of the attached cells on 
the micro-fibers with a different seeding density. 
 
4.3.3 Endothelial Cell Tubulogenesis on Microvascular Scaffold 
With the previously obtained optimal seeding conditions, the HDMECs were 
successfully seeded on the scaffold and cultured for 48 hours without any addition 
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of exogenous growth factors or angiogenic agents. The slice view of the confocal 
image of a single PLA-PEG micro-fiber with HDMECs cultured and stained is 
presented in Figure 4.31A. As can be seen in this slice view (X-Y view), the cells 
preferentially spread along the axial direction of the micro-fiber scaffold. The 
scaffold displayed in the figure had a diameter of 12.4 µm, and the average 
distance between adjacent cells was 15.1 ± 3.2 µm. The circular shape in the right 
of Figure 4.31A is the X-Z view; this image demonstrates the two cells connected 
circumferentially around the scaffold and formed a lumen. Figure 4.31B shows the 
confocal volume view of the HDMECs covered scaffold.  From the 3D view, it can 
be observed that the whole surface of the scaffold was covered with the cells along 
the axial direction. The inserted cross-sectional image confirmed the confluent 
monolayer formation of the HDMECs due to the cells wrapping circumferentially 
around the scaffold. In Figure 4.31C-D, the HDMECs demonstrated an elongated 
shape on the surface of the three-dimensional branched micro-fiber with an aligned 
orientation that was different from the typical two-dimensional spread shape with 
random orientation. The morphological change of the cells suggests a distinctive 
cellular response to the three-dimensional scaffold. The result also confirmed the 
previously reported contact guidance phenomenon whereby the endothelial cells 
follow the direction lead of natural or artificial scaffolds architecture to mediate their 




Figure 4. 31 Confocal images of a single PLA-PEG fiber with the HDMECs cultured 
and stained to highlight the nuclei (blue) and cytoskeletons (red) A) Slice view; B) 
Volume View; Fluorescent images of the HDMECs stained to highlight the nuclei 
(blue) and actin cytoskeletons (red) at C) the surface of a branched PLA-PEG 
scaffold, and D) the bottom of the 24 well plate 
 
In order to further study the physiological characteristics of the HDMECs 
growing on the scaffold, immunostaining for vascular endothelial cadherin (VE-
cadherin) was employed to identify cell-cell junctions. Figure 4.32A presents a 
single PLA-PEG copolymer scaffold with its surface covered by the HDMEC 
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monolayer. The inserted cross-sectional image confirmed the cells have grown 
around the circumference of the scaffold. In Figure 4.32B, the cell-cell junctions 
were demonstrated via VE-cadherin expression. Recent findings have uncovered 
that endothelial cell-cell junctions play an essential role in maintaining structural 
integrity and transferring intracellular signals that determine cell growth, cell 
polarity, lumen formation, and interaction with pericytes and smooth muscle 
cells[206]. Additionally, the endothelial cell-cell junctions have been involved in 
several complex signal transmission that controls the vascular permeability and 
barrier function in an adult vessel[207]. The VE-cadherin expression of the 
HDMECs on the scaffold demonstrated the neighboring cells adhered to each 
other and formed cell-cell junctions. These images also suggest that the cell-
covered scaffold strategy has the ability to form a microvascular network in vitro.  
 
Figure 4. 32 Confocal image of a single PLA-PEG fiber with the HDMECs cultured 
and stained to highlight the nuclei (blue) and VE-cadherin (green) with a cross-
sectional image (insert) at 40X magnification A), and B) partial enlargement of (A) 




The HDMECs grown on the PLA-PEG copolymer were imaged at higher 
resolution by using the SEM. As illustrated in Figure 4.33A, similar results for the 
previous immunostaining confocal images were observed in the SEM images. The 
scaffold displayed in the figure had a diameter of 13.1 µm, and the average size of 
the HDMECs was 17.6 ± 2.86 µm. After the fixation and dehydration, the HDMECs 
were observed to be evenly distributed on the surface of the scaffold. It can also 
be observed that the long axial of the elongated cells aligned along the axial 
direction of the scaffold. Figure 4.33B-D showed several enlarged images of 
connections between adjacent cells (pointed with the red arrow); these images 




Figure 4. 33 A) SEM image of a single PLA-PEG fiber with the HDMECs cultured 
for 48 hours; B), C), and D) partial enlargements of (A) for cell-cell junctions 
 
In order to determine whether the cells on the surface of the PLA-PEG 
scaffold are still alive after two days of culturing, a live/dead assay was utilized to 
examine the viability of the HDMECs on the scaffold. Figure 4.34 presents the 
fluorescent images with different magnifications: A) 4X, B) 10X, and C) 20X. The 
upper row images were captured under the blue filter showing the live cells, and 
the lower row images were taken under the green filter showing the dead cells. It 
can be seen that the cells on the suspended scaffold are all alive and grew along 
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the axial direction of the scaffold. Several dead cells could be observed in the 
background, which is the bottom of the 24-well plate at a different focal plane. This 
result suggests the cells that cover the scaffold are still active and could be cultured 
in the ECM for the further study.  
 
Figure 4. 34 Fluorescent images of the HDMECs stained to highlight the live cells 
(Calcein, green, upper row) and dead cells (EthD-1, red, lower row) at different 
magnification: A) 4X, B) 10X, and C) 20X  
 
After demonstrating the ability to grow a confluent HDMEC monolayer on 
the single PLA-PEG micro-fiber scaffold, the HDMECs were also seeded and 
cultured for 48 hours on a PLA-PEG branched structure. The 3D reconstruction 
confocal image is presented in Figure 4.35A. It can be seen that the cells were 
patterned along the branched structure with topographic guidance. No cell 
connections between the neighboring branches were observed, which further 
confirmed the cellular orientation response to the three-dimensional scaffold. 
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Figure 4.35B shows the partial enlargement of the branched structure; similar 
results compared to the previous single micro-fiber scaffold were obtained. The 
cells appear to spread along the axial direction on the scaffold and the cross-
sectional image (inserted) confirmed the cells are tightly enveloping the entire 
circumference of the scaffold. The successful formation of HDMECs-covered 
branched structures suggests our approach is highly feasible for the construction 
of the microvascular network in vitro.  
 
Figure 4. 35 A) 3D reconstruction confocal image of HDEMCs on PLA-PEG 
branched structure stained for the nuclei (blue) and actin cytoskeletons (red) at 
20X magnification, B) partial enlargement of (A) with a cross-sectional image 
(insert) at 40X magnification 
 
4.4. Prevascularization of Hybrid Constructs 
We have introduced that collagen, fibrin, and MatrigelTM could be used as 
ECM to provide a three-dimensional environment that structurally supports cells 
and allows for a diffusion of nutrients. After we successfully obtained the cell-
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covered scaffold, we want to further encapsulate it into an ECM to get a 
vascularized sheet to allow cells to attach and maintain a lumen shape after the 
scaffold is degraded. To demonstrate this conceptual method, we embedded the 
cell-covered scaffolds into a 1 mg/mL Type I collagen hydrogel and culture the 
hybrid constructs for an additional three days. Figure 4.36A shows the hybrid 
structures attached on the acrylic frame (highlighted in the red dot square) after 
three days of culture. The vascularized sheet was a soft, semi-transparent, and 
moisture-absorbing film. After carefully cutting the four edges of the film, the 
vascularized sheet detached from the frame. However, the sheet immediately 
twisted and folded due to the internal tension (Figure 4.36C and F, pointed with 
the red arrow). Surprisingly, the sheet could unfold itself just by adding a few drops 
of PBS solution. As can be seen in Figure 4.36D-E, the vascularized sheet 
gradually extended itself under the buoyancy of the PBS solution. Eventually, the 
vascularized sheet completely unfolded itself to form a free-standing film that is 
floating in the PBS solution. In the classical “bottom-up” approach for the tissue 
engineering, the key idea is first to create intermediate “modular tissues” and then 
assemble them into the desired engineered tissue[208]. Guided by this strategy, 
we added another vascularized sheet into the system and it also unfolded 
automatically (Figure 4.36F-H). These two or even more two-dimensional sheets 
could be used as the “modular tissues” that are eventually stacked on each other 
to form more advanced three-dimensional architecture. Figure 4.36B shows the 
vascularized sheet after fixation and dehydration became dry and brittle. It is worth 
noting that after a series of graded ethanol washes, the sheet needed to be taken 
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out from the frame and transferred to a PTFE substrate before it completely dried. 
Otherwise, the sheet will stick to the bottom of the wall plate and will be difficult to 
peel off.  
 
Figure 4. 36 Optical images of the vascularized sheets: A) on the custom acrylic 
frame, B) after fixation and dehydration, C-E) hybrid structure unfolded itself in the 




Using fluorescent staining, the inner structure of the vascularized sheet 
could be observed and the growth status of the cells in the ECM could be evaluated. 
As shown in Figure 4.37A-B, the HDMECs on both a single micro-fiber and a 
branched structure scaffold could be seen. Although the images are a bit hazy 
(may be caused by the scattering of the fluorescent light in the opaque collagen 
gel), we can still confirm that the HDMECs are growing along the axial direction of 
the scaffolds. No migrated cells near the scaffold were observed, indicating that 
the HDMECs were well attached on the scaffolds with the help of mechanical 
support and the diffusion of nutrients aided by the ECM. Figure 4.37C-D shows 
the 3D reconstruction confocal images of the hybrid structure. Notably, the inserted 
cross-sectional image in Figure 4.37C shows the cells were wrapping the 
circumference of the scaffold and the lumen shape was still maintained. Also, the 
cells in the 3D confocal images were observed to not migrate from the initial 
scaffold. To further evaluate the viability of the cells after they were encapsulated 
into the ECM, the live/dead assay was utilized and the results are shown in Figure 
4.37E-F. One can see most of the cells on the scaffold were still alive. However, a 
few granule-shaped cells and dead cells could be observed, suggesting the cells 
may not last long on the scaffold. This behavior may be caused by contact 
inhibition, which was often found in the monolayer endothelial cells culture if there 
was no chemotactic or mechanical stimuli[209, 210]. Nevertheless, this approach 






Figure 4. 37 Fluorescent images of a A) single micro-fiber and a B) branched 
structure stained for the nuclei (blue) and actin cytoskeletons (red); 3D 
reconstruction confocal images of a C) single micro-fiber and a B) branched 
stained for the nuclei (blue) and actin cytoskeletons (red); E-F) fluorescent images 
of the live/dead assay stained to highlight the live cells (Calcein AM, green) and 
dead cells (EthD-1, red).  
To examine the microscopic morphology of the hybrid structure, the 
dehydrated sheet was cut perpendicular to the direction of the micro-fiber scaffold 
by a blade and visualized through the SEM (Figure 4.38A). Figure 4.38B presents 
a 106X magnification the SEM image to show the overall perspective of the cross-
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sectional cut. Two parallel micro-fiber scaffolds could be identified. Three 
distinctive spots were selected to further study the microstructures. The side view 
of the hybrid structure is shown in Figure 4.38C. We could see the dehydrated 
collagen network is composed of fiber bundles and small pores. The fibrous and 
porous microstructure could supply not only mechanical support, but also allow the 
diffusion of nutrients to the cells. Figure 4.38D shows the cross-sectional view of 
the collagen hydrogel film: the average thickness of the film is approximately 18 
µm. We can see the dehydrated film consists of several layers that are 
interconnected with small pores. The highly porous microstructure has been shown 
to play a critical role in cells proliferation and media diffusion. Figure 4.38E 
presents the cross-sectional image of the vascularized sheet. The circular shape 
of the scaffold, the fibrous nature of the ECM, and several pieces of cell debris 
could be seen from the incision. Figure 4.38F is a sample where the cutting 
process accidentally broke the side of the collagen hydrogel. We could see more 
intact cells are attached on the scaffold. This image could further confirm that the 
vascularized sheet exhibits scaffold-cell-ECM interactions. From these images, 
there is still no evidence to suggest the scaffolds have degraded because the 
scaffolds are still tightly wrapped in the ECM. Also, the previous degradation 
experiments showed that after three days, an obvious mass change of the 




Figure 4. 38 A) Optical image of the dehydrated vascularized sheet after radial 
cutting. SEM images of B) an overview of the cross section (106X magnification), 
C) side view of the dehydrated ECM (4.39 KX magnification), D) cross-sectional 
view of the dehydrated ECM (1.98 KX magnification), and E, F) cross-sectional 
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view of the vascularized sheet with scaffold-cell-ECM interaction (6.0 KX 
magnification) 
In order to further study the scaffold degradation behavior inside of the ECM, 
we increased the culture time to two weeks. Figure 4.39 presents the cross-
sectional views of the vascularized sheet under different culture times. The upper 
row images (A1-A3) show several examples of the samples under three days of 
culture. Similar to the previous result, the circular-shaped micro-fiber scaffold 
(highlighted by the green dashed line) was closely covered by the collagen gel, 
and no space could be seen between them. Also, no visible HDMECs were 
observed in these views since the connection between the scaffold and collagen 
was very tight and the endothelial cells may not have been distinguishable due to 
the small cell thickness (500 nm). It is worth noting that most of the samples under 
two weeks of culturing were not observed to have obvious scaffold degradation. 
The lower images (B1-B3) show several representative examples of vascularized 
sheet that have aby indication of scaffold degradation. As can be seen, these 
micro-fiber scaffolds showed various cross-sectional shapes, suggesting they 
were experienced different degradation degree. For instance, the scaffold in 
Figure 4.39B-1 shows an irregular polygon-shaped scaffold and the lumen outline 
(highlighted in the red dashed line). The cavity on the scaffold surface may have 
been formed by the surface erosion degradation mechanism; the measured cross-
sectional area ratio of the scaffold and the lumen is approximately 82.3%. In 
Figure 4.39B-2, a taper-shaped scaffold with a 44.5% scaffold/lumen outline ratio. 
This decrease in ratio may suggest more scaffold materials degraded away in the 
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same culturing environment. These differences in degradation may be caused by 
both the different diffusion rates within the complex collagen network and unknown 
interactions between the ECM, cells, and the scaffold. In Figure 4.39B-3, we 
observed a perfect lumen within the  collagen hydrogel without any scaffold 
remaining. However, this result does not conform to the previous degradation test 
result in which the PLA-PEG (75:25) copolymer was not able to completely 
degrade in two weeks. We speculated three reasons as to why the scaffold 
degraded in this sample: (1) the scaffold broke or pulled away during the cross-
sectional cut; (2) the scaffold may have experienced bulk erosion and the debris 
was washed away by the media; (3) this sample was left in the desiccator for two 
weeks before taking SEM images and the vacuum environment may have caused 
the scaffold  to detach from the dehydrated collagen gel. The future challenge 
involves better understanding the degradation mechanism of the biopolymer 
scaffold within the collagen hydrogel, being able to accelerate the hydrolyzation 
rate by adding a catalyst or finding a new material with a faster degradation rate to 




Figure 4. 39 SEM images of the cross-sectional view of the vascularized sheets 






CHAPTER 5:  CONCLUSIONS AND FUTURE DIRECTIONS 
The capability to selectively produce microcirculatory vessels is critical to 
the emerging field of tissue engineering. In order to produce microvasculature, a 
scaffold is required to support and stimulate endothelial cell adhesion and growth. 
The primary goal of this project was to develop both a protocol for the construction 
of a precisely positioned, three-dimensional, suspended biopolymer scaffold with 
varying diameters and a conceptual scaffold-covering strategy to create 
physiological microvascular networks in vitro.  
In this work, we extended the direct-write technique and adopted the 3-Axis 
robotic dispensing system developed by Dr. Scott Berry and Dr. Hanwen Yuan, 
who previously worked in our laboratory. Gelatin, PLGA, Gelatin/PLGA composites, 
PLA, PLA-PEG copolymers were successfully processed into precisely-positioned, 
suspended micro-fibers and branched structures. The geometries of the micro-
fibers and the branched structures were successfully controlled during fabrication 
to match the microvascular-scale (5 - 40 µm). We have demonstrated the ability to 
control the spatial orientation of the branched structures and the relative errors for 
the actual and design branching angles were less than 9%. We also demonstrated 
the ability to develop the branched structures with varying diameters so that they 
could better mimic the real capillary system structure of arterioles, capillaries, and 
venules. Moreover, several complex structures such as web structure with multi-
intersections, parallel fiber array, and overlapping fibers with the orthotropic 
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structure were also successfully fabricated by precisely controlling the dispensing 
tip to move between the predefined spatial spots.  
In addition to fabricating the biopolymer micro-fibers, we expected to better 
understand the fiber formation mechanism behind the thinning dynamics of 
biopolymer solutions as well as determine what process factors affected the micro-
fiber yield and diameter. The direct-write process was characterized by a single 
polymer/solvent system (gelatin/TFE) through the unbalanced four factors multi-
level full factorial design of experiment. Biopolymer solutions’ concentration, 
needle’s inner diameter, feed rate, and fiber length were confirmed as the 
significant factors that could both affect fiber yield and diameters (p = 0.000 for 
both). Next, a dimensional analysis was performed to reduce the 6 physical 
variables to 3 dimensionless parameters, followed by the employment of a linear 
regression analysis to generate an empirical model based on the dimensionless 
parameters. This empirical model revealed the correlation between the fiber 
diameter, polymer solution properties, and system process parameters. Then, the 
empirical model was validated by various biopolymer/solvents systems and the 
predicted and experimental data of micro-fibers diameters was compared. By 
excluding the out-of-boundary data, the mean absolute deviation was 4.30 µm, 
and the mean absolute percentage error was 38.22%. 
After considering the multi-factors of the direct-write yield, the 
biodegradation rate, and the endothelial cells adhesion ability and viability 
comprehensively, the PLA-PEG (75:25) copolymer was selected to be seeded with 
HDMECs. The optimized seeding conditions were as follow: (1) the bottom of the 
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24-well plate was blocked by 0.01% BSA solution; (2) the scaffold was surface 
modified by 5 µg/mL fibronectin solution; (3) a seeding density of 80,000 cells/cm2 
was selected. The HDMECs cultured on suspended scaffolds were observed to be 
living on the surface of the three-dimensional branched structures and had an 
elongated shape with an aligned orientation. The 3D reconstructed confocal 
images confirmed the HDMECs proliferated both along the axis and around the 
circumference of the micro-fibers and to create a confluent monolayer of cells on 
the surface of the micro-fiber. The VE-cadherin expression of the HDMECs 
demonstrated the neighboring cells adhered to each other and formed cell-cell 
junctions. 
The last step for the scaffold-covering strategy is to encapsulate the cell-
covered scaffold into the ECM and let the scaffold degrade through hydrolysis. In 
this study, we successfully embedded the cell-covered scaffold into a collagen gel 
and cultured for three additional days. The fluorescent and confocal images 
showed the viable cells were still wrapped on the scaffold and maintained the 
cylinder-shaped monolayer. The cross-sectional SEM images confirmed the ECM-
cell-scaffold interactions. No visible scaffold degradation was observed after three 
days of culture, while a few samples showed obvious mass loss (17.7% - 55.5%) 
after two weeks of culture through the cross-sectional images. Although the 
scaffold was not completely degraded as we expected in this study, we 
demonstrate the ability to obtain a flexible and free-standing “modular tissue,” 




In this dissertation, we developed the proof-of-concept scaffold-covering 
strategy to create a microvascular network with the direct-write scaffold method in 
vitro. Based on the present progress and current understanding of the formation 
mechanism of the microvasculature, the following recommendations are made 
with respect to future work: 
(1) Develop a new biodegradable polymer with a faster degradation rate 
(less than a week) which could be direct-written as well. For the PLA-PEG 
copolymer, a polymerization catalyst such as stannous octoate could be used to 
prompt the reaction rate and increase the ester bond ratio, therefore accelerating 
the hydrolysis process[205].  
(2) A co-culture system could have potential in the construction of 
microvascular systems, specifically enhancing the cell lumen integrity and viability. 
Supporting cells could include pericytes, vascular smooth muscle cells, and 
mesenchymal cell[211]. 
(3) Further experimentation should be conducted to gain insight into the 
utilization of specific growth factors such vascular endothelial growth factors, 
junctional proteins such as the vascular endothelial cadherin, and extracellular 
proteins such as EGF like domain 7 during the capillary system formation 
process[212].  
(4) Manipulation of external forces–such as cyclic and static strain, as well 
as flow-induced shear stress–may help the HDMECs suppress apoptosis, 
enabling the cells to survive during the scaffold hydrolysis degradation. These 
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external forces may also help to create a perfusable vessel and maintain the lumen 
integrity of the cell monolayer. 
(5) An in vivo animal study will be beneficial to further evaluate the potential 
of “modular tissue” sheets developing into a three-dimensional functional 
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